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ÖZGE CAN 
 
 
ABSTRACT 
 
Many organisms are exposed to subzero temperatures in nature and can survive 
these temperatures by the effect of antifreeze proteins (AFPs), which inhibit ice crystal 
growth and change the morphology of ice crystals. Although the effects of these proteins, 
such as recrystallization inhibition, ice growth inhibition, and crystal habit changes, are 
known, a conclusive description of the protein-ice crystal interaction including 
interaction energy, surface coverage, and lifetime of adsorbate has been elusive. 
In this study, different antifreeze protein constructs are designed and expressed 
such that they can be conjugated to polymers to increase the thermal hysteresis activity 
especially at low concentrations. Trimers of these proteins are also constructed using a 
foldon domain attached to their C-terminus. New constructs of type I and type III 
antifreeze proteins yield significantly higher thermal hysteresis activities than the native 
protein.  
Furthermore, we determine the binding equilibrium constant for a type III fish 
antifreeze protein and the relationship between thermal hysteresis and surface coverage 
for this protein. This is possible using experimental data from a two-domain antifreeze 
protein and its related single domain protein. The classical Langmuir isotherm is used to 
 v
describe the equilibrium exchange of the single domain type III AFP molecules at the ice 
crystal surface, while a modification of the Langmuir isotherm is derived to describe the 
adsorption of the two-domain AFP. Because the protein adsorption is governed by 
different isotherm relationships, there are two independent data sets allowing the 
determination of the two unknowns of surface coverage and binding energy. The data 
yield a binding equilibrium constant of 1.9 mM-1 for the type III AFP-ice interaction. The 
analysis results in a relationship between surface coverage and thermal hysteresis, as well 
as kinetic equations of the adsorption of the proteins onto the ice surface.  
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Overview 
Many organisms are exposed to subzero temperatures in nature. There are various 
places in which this exposure may occur at night and also at high altitudes in equatorial 
regions. Fish in the Antarctic Ocean have been living for approximately 25 million years 
and the important fact is that they have been showing rapid reproduction and growth 
indicating how well they have adapted to cold environment [1]. An interesting and 
complex adaptation to life in those challenging environments is the expression of 
antifreeze proteins (AFPs) that inhibit ice crystal growth [2]. The nucleation of ice 
crystals in cells and tissues will typically occur first in the extracellular fluid before 
intracellular fluids freeze. This naturally protects cells and tissues from freezing at 
temperatures slightly below the freezing point [3]. 
 Antifreeze glycoproteins were first found in Antarctic teleost fish 30 years ago by 
Art DeVries and his colleagues. Soon after this discovery, several other species of 
antifreeze proteins were identified [4]. Antifreeze proteins allow organisms to survive at 
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subzero temperatures or at temperatures lower than the freezing point of their bodily 
fluids by inhibiting ice crystal growth. This phenomenon gave rise to many studies in 
order to gain more information as to how they prevent the ice crystal growth [5]. There 
have been several theories some of which have been experimentally proven and some 
still remain as a question [6]. However the exact mechanism is not known, the major role 
of antifreeze proteins in ice binding is suggested as hydrophobic interactions, hydrogen 
bonding and van der Waals interactions which are required for the optimal surface-
surface complementarity [6-9]. AFPs bind to specific planes of the ice surface, which in 
turn stops subsequent growth at temperatures below the colligative melting point. The 
interaction of AFPs with the ice crystal causes thermal hysteresis, which is a difference 
between freezing and melting temperatures. AFPs also prevent the redistribution of the 
water between ice crystals and the solution referred to as ice recrystallization [10].  
 
1.2 Significance and applications 
There are numerous situations in which appropriate preservation of the tissues or 
organs is needed to provide sufficient time for transplantation. Heart and liver 
transplantation for example are traditional surgical techniques for the treatment of end 
stage organ failures [11, 12]. The storage time for a donated heart or liver is limited to 5 
to 12 hours with current preservation techniques. This does not provide sufficient time for 
optimizing donor-recipient tissue matching and causes significant challenges in the organ 
transportation process [13]. Additional promise for the use of cellular therapy for 
treatment of heart disease often requires long term storage of cells and tissues. When 
cellular solutions freeze, cryopreservation becomes unsuitable due to damage caused by 
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ice formation that disrupts cell membranes or causes osmotic stress by naturally 
increasing salt concentration in the solution [11]. Thus, it is important to investigate the 
storage (cryopreservation) of cells, tissues, blood, and organs for increasing the success 
in the treatment of cardiovascular and other diseases [2, 10, 11, 14, 15]. One promising 
approach in improving the survival of cells after cryopreservation is by using antifreeze 
proteins as an additive. 
In addition to the cryogenic storage of cells and tissues, there are also various 
places in petrochemical processes in which the effective heat transfer is required to 
reduce the cost of the processes. Heat transfer equipments such as heat exchangers are the 
heart of the petrochemical processes and the effectiveness of such processes is 
significantly dependent on the efficient heat transfer throughout the various 
petrochemical systems.  
Using ice slurry systems is of great interest because of the latent heat phenomena 
of the ice that is observed during ice melting [16-25]. However, it is crucial to overcome 
the difficulties observed during transportation of ice slurry such as the ice crystal growth 
which can cause clogging of pipelines reducing their effectiveness [21, 26, 27]. It is 
extremely important to find new functionally thermal fluids or the modifications of the 
existing ones to overcome these challenges [23, 24, 28-30]. One promising approach in 
improving the utilization of ice slurry systems is using antifreeze proteins (AFPs) as an 
additive to obtain an efficient heat transfer fluid for a particular application in the 
petrochemical industry [19, 21, 22, 25, 31, 32]. 
Creating superior AFP constructs which would have increased thermal hysteresis 
activities especially at low concentrations would make it easier and economical to use 
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them as an additive in these systems. In the light of the developing bioconjugation 
technology, designing novel synthetic materials that are suitable to use in such 
applications is very promising. 
 
1.3 AFP structures 
Antifreeze proteins (AFPs) are ice-binding proteins found in various organisms 
(such as fish, insects, and plants) exposed to freezing conditions [9]. Although AFPs are 
structurally diverse, they typically present a relatively large, flat and slightly hydrophobic 
surface for binding to ice [9, 33-36]. Amino acid composition varies considerably both 
between species and sometimes within species. Also, they have a wide range of 
molecular weights from 5 kDa for a type I fish AFP to 36 kDa for AFP from winter rye 
[37]. Their structural diversity together with an inability to examine the AFP-ice 
interaction directly, has made structure function studies difficult [9]. AFPs generally 
display well defined folds and conformations. Their structures range from the single α-
helices of type I AFP, to the globular types II and III AFPs (Figure 1.1). Type I AFP 
shows striking regularities in the positioning of suspected ice-binding motifs, while types 
II and III AFPs show no obvious repetitive components on their surfaces. Indeed, these 
proteins appear to share little in common other than their defining characteristic of ice-
growth inhibition. The type I AFP is a single α-helical fold which is slightly curved 
amphiphilic fold. In this helical structure, there is a large proportion of alanine residues 
[38]. Compared to the other AFPs, there is a more detailed structure for the type III 
AFPs. Ice binding sites are readily determined by site directed mutagenesis and found to 
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be relatively hydrophobic [39]. Thus, it is important to note that hydrophobic residues on 
the side chain play important role as well as their packing strength. 
Type III AFP is a 7 kDa globular protein found in Antarctic eel or ocean pouts 
and is comprised of around 65 amino acids [35]. As a result of high resolution X-ray and 
NMR studies, it is found that type III AFP has a compact fold with several  strands and 
one helical turn and a flat hydrophobic surface to bind to the ice crystal [3, 40-42]. Ice 
binding models of type III AFP suggest that this protein adsorbs to the prism plane of the 
ice crystal [43, 44]. There have been various isoforms of this protein studied. One of 
them, RD3, is unique because it is comprised of two type III AFP domains connected by 
flexible nine-residue linker [45]. The two domains are free to bind to the ice surface 
independently [46], resulting in larger thermal hysteresis than the single domain proteins 
at low concentrations [47]. 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Antifreeze protein structures. Counter clockwise from top left: Type I AFP 
from winter flounder, Type II AFP from sea raven, and Type III AFP from ocean pout. 
PDB IDs are 1WFA [36], 2afp [48] and 1ucs [49], respectively. Figures were produced 
using DeepView/Swiss-PdbViewer software program [50]. 
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1.4 Current trends on AFP research 
Even though AFPs comprise a structurally diverse class of proteins, they have in 
common the ability to bind to ice and inhibit its growth. This action at ice-solution 
interface leads to a lowering of the nonequilibrium freezing point below the melting 
point, referred to as thermal hysteresis. Based on the assumption that AFPs interact with 
ice through adsorption to specific planes, this would indicate that as long as the 
supercooling is below a critical value, there will be sufficient amount of time for the AFP 
to align along the energetically favorable direction on the appropriate crystal plane. There 
might however be AFP molecules adsorbing to the surface occasionally but these will not 
be able to completely inhibit crystal growth [29]. AFPs are incorporated within the ice 
when it freezes because of their affinity for its surface. These AFPs can act as 
recrystallization inhibitors even in the frozen state by inhibiting the growth of large ice 
crystals at the expense of small ones, particularly when ice approaches the melting 
temperature and becomes more fluid [51]. Recrystallization takes place most rapidly at 
temperatures where ice slurries are used that are just below freezing and during warming 
from the glassy state. Extremely low concentrations (100 µg/L) of AFP are effective in 
inhibiting ice recrystallization [21]. Recrystallization inhibition has been shown to occur 
in the presence of AFPs performed [2, 21, 22, 52-55]. 
There have been several studies in the literature in which they have investigated 
the ice binding mechanism of the AFPs [41, 56-62]. At the first glance it seemed like 
hydrophilic residues on the surface of the protein were causing the ice binding activity 
because when they changed the hydrophilic sites using site directed mutagenesis they 
obtained 90% loss of activity and they thought the mismatch between the ice binding site 
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of the protein and the ice caused reducing the strength of the hydrogen bond [56]. 
Although hydrogen bonding was thought to be the primary ice binding mechanism 
previously [43], there have been other factors such as steric complementarity of the 
protein, van der Waals interactions at the ice protein interface, etc. It appears that polar 
side chains of the protein are not surface accessible so that they can not form efficient 
hydrogen bonds. Another factor inhibiting hydrogen bonding is that limited amount of 
water molecules in the ice surface have also limited ability to find protein molecules in 
the ice surface to hydrogen bond. 
Other research groups suggested that this loss of activity was the result of the 
steric interference with the docking of the AFP and the ice [4]. Effects of steric mutations 
were also investigated by Deluca et al., in 1998 by replacing the Ala16 with the larger 
side chains and they found that there are multiple causes for the loss of the thermal 
hysteresis activity and the ice morphology including the tightness of the side chain 
packing and the rigidity of the ice binding surface. These studies were extended by other 
groups and the major role in ice binding was proposed as hydrophobic interactions, 
hydrogen bonding and van der Waals interactions which are required for the optimal 
surface-surface complementarity [7, 8]. 
Chao et al. studied the effect of mixing different types (type I, type II and type III) 
of AFPs on the thermal hysteresis activity. Mixtures of these proteins produced different 
ice crystal morphologies but did not affect the thermal hysteresis activity. They suggested 
that these proteins are independently active and do not require protein-protein 
interactions for binding to the ice [63]. 
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Kristiansen et al. investigated the effect of salt concentration in the solution on the 
thermal hysteresis activity. They suggested that the salts present in the solution decreases 
the solubility of the proteins around the ice crystal leading to the accumulation of the 
AFPs available for adsorption. This effect is explained by so-called salting out effect 
[64]. However, the ability of the proteins to bind to the ice crystal in the insoluble stage 
remains unclear.  
 
1.5 AFPs in cell/organ preservation 
There are several studies in which they have used antifreeze proteins in cell or 
organ preservation. Chao et al. investigated the infIuence of type III AFP mutants on 
hemolysis of cryopreserved red cells [14]. They used different types of AFPs which were 
preliminarily purified and their antifreeze activities were measured as thermal hysteresis. 
Then, they collected human blood from healthy volunteers which was processed to obtain 
red cells then were cryopreserved. Samples were thawed in air at room temperature, 
which leads to very slow warming. They concluded that the relative thermal hysteresis 
activity of the type III protein and the mutant directly correlates with their capacity to 
inhibit ice recrystallization and to protect red cells during a freeze-thaw cycle. They also 
supported their hypothesis by another study performed by Knight and Duman, 1986, that 
inhibition of ice recrystallization by AFPs can help cells survive during freezing and 
thawing [54]. 
  Amir et al. in 2003 were first to demonstrate successful subzero cryopreservation 
of mammalian hearts using AFP I and AFP III in an in vivo heterotopic heart 
transplantation model [13]. All hearts preserved at subzero temperatures using AFP I or 
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AFP III survived showing excellent viability. They concluded that subzero preservation 
of mammalian hearts using type I and type III AFPs is feasible.  
In another study performed by Amir et al. in 2004, they aimed to evaluate whether 
lowering the temperature can increase the preservation time of a rat heart and whether 
prolonged subzero preservation using AFPs improves the viability of harvested hearts 
compared to hearts preserved using standard techniques at 4°C [12]. They concluded that 
their results show a clear benefit of subzero nonfreezing storage of rat hearts using AFPs. 
They were able to demonstrate that using AFPs improves survival in subzero preservation 
of rat hearts. 
   
1.6 AFPs with increased thermal hysteresis activities 
In regard to increasing thermal hysteresis activity, superior AFPs have been 
investigated by a number of researchers. HPLC6 is the most extensively characterized 
type I AFP, which has three repeats of 11 amino acid residues [65]. Chao et al. 
investigated one of the longer type I serum AFPs in winter flounder plasma. This 
construct was named as AFP9 and had four repeat sequence. They found that this longer 
protein is more active than its shorter isoform even tough it has fewer ice binding 
residues in its structure. They suggested that longer size would have a positive effect 
increasing the thermal hysteresis activity [66]. After this discovery of the larger AFP in 
winter flounder species, which is much more active than the type I AFPs, the same group 
found another longer AFP in American plaice with a molecular weight of approximately 
17 kDa. This protein is five times longer than the 3 repeat type AFP and exhibited 
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significant thermal hysteresis activity even at low concentrations, i.e. 2.2 oC at 0.4 mg/ml 
[67, 68]. 
 The improved thermal hysteresis activity was not only studied for type I AFPs. In 
a study performed by Miura et al., they showed the enhanced activitiy of the type III 
dimer connected by a nine residue linker [47]. They compared the activity of the 
monomer of the same protein with its dimer and found that the dimer was 2 times as 
active as the monomer. This enhancement was even more pronounced yielding thermal 
hysteresis activities as much as 6 times greater than the monomer for lower 
concentrations. This effect was explained by the assumption that the average distance 
between the dimer molecules is smaller than that of the monomers. Hence, in order to 
saturate the ice surface and stop the ice growth, relatively small amount of dimer would 
be needed as compared to the monomer. More detailed investigation of the increased 
activity of the type III dimers was presented in another study [61]. They showed that the 
recombinant dimer type III AFP from Antarctic eel pout is twice as active as its 
monomer. However, when they inactivated one of the domains, its activity was reduced 
to 1.2 fold than that of the monomer. When two monomers were linked through a 
disulfide bond such that two domains could not bind to the ice surface simultaneously, 
the dimer was again only 1.2 times as active as its monomer. These findings were used to 
conclude that the enhanced activity of the dimer results from the ability of the two 
domains of the dimer to bind to the ice surface at the same time by doubling the ice 
binding surface area. The increased thermal hysteresis activity of type III dimers was 
further investigated by creating multimers (tandem repetition of dimers, trimers and 
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tetramers) of the various combinations of the monomers [69]. They found that as the size 
of the molecule increases, thermal hysteresis activity also increases. 
 Similar type of studies was carried out using insect AFPs by adding and deleting 
coils from the structure of the protein. It has been shown that the enhanced activity of the 
longer insect AFPs results from the greater size and especially the greater ice surface 
binding area [70, 71].  
   
1.7 Theories on AFP/ice interactions 
Among AFPs, there is a considerable variance in thermal hysteresis activity. For 
example, hyperactive insect (Tenebrio molitor) AFP [72] has a thermal hysteresis activity 
of 4.1˚C at a concentration of 150 M, whereas for the same concentration, two-domain 
type III (RD3) [69] and type I (winter flounder) [73] AFPs can only depress freezing 
point by 0.25˚C and 0.17˚C, respectively.  
Although numerous studies have been performed to investigate the interactions 
between AFPs and the ice crystal, an explicit description of the interaction has been 
elusive [21, 74, 75]. In developing a model of the protein-ice interaction, two seemingly 
contradictory experimental observations are particularly important: irreversible 
adsorption of AFPs to ice and a concentration dependence of thermal hysteresis activity. 
The predominant model describing thermal hysteresis is based on an adsorption 
inhibition mechanism derived using the Kelvin effect [76]. By adsorbing to the ice 
surface irreversibly, AFPs are thought to prevent ice crystal growth by increasing 
curvature of the exposed ice surface, which makes further ice growth energetically 
unfavorable [6, 44]. This is consistent with the observation of irreversible adsorption 
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using fluorescence microscopy [77]. However, it has been difficult to reconcile 
irreversible adsorption with the concentration dependence of thermal hysteresis. Other 
theories have been developed to account for the concentration dependence of thermal 
hysteresis, but are based on a reversible equilibrium between AFP and ice at all 
temperatures [62, 78, 79], which is inconsistent with the experimental observations 
described above.  
One recent model presented by Kristiansen and Zachariassen accounts for both 
irreversible adsorption and concentration dependence of thermal hysteresis [6]. 
According to this model, at the bulk melting point there is a reversible equilibrium 
distribution of AFP molecules between the ice-water interfacial region and bulk water 
phase, resulting in the concentration dependence of thermal hysteresis. At temperatures 
lower than the melting point AFP molecules become irreversibly adsorbed onto newly 
formed ice crystal surfaces. This illustrates the possibility of both a reversible and 
irreversible adsorption by AFPs at different stages of ice formation. 
To describe the reversible adsorption, it is important to determine the energetics 
of the AFP adsorption to the ice crystal surface. However, it is almost impossible to 
determine the binding energy of the AFP with traditional experimental methods because 
of the dynamic nature of the ice-water interface. The concentration dependence of 
thermal hysteresis is one measurement that is readily available, but the relationship 
between thermal hysteresis and binding energy is not evident. Experimental difficulties in 
AFP research have made simulations and analytical models necessary to overcome this 
challenge [62, 75, 80, 81]. There have been energy minimization, molecular dynamics 
and molecular simulation studies to determine the binding face of the AFPs by 
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calculating binding energies of individual possible binding sites [39]. However, there is a 
great difference between calculated energies likely owing to the level of complexity of 
the models used. Winter flounder AFP-ice interaction energy was found to be 84 
kcal/mol in vacuo [82] and 157 kcal/mol in water [83] using energy minimization and 
molecular dynamics simulations. On the other hand, AFP/ice interaction energy has been 
calculated as low as 4.9 kcal/mol in terms of Gibbs free energy for winter flounder AFP 
using Monte Carlo simulations [62]. Furthermore, interaction energies of several 
hundreds of kilocalories per mole were calculated for different patches of the ice binding 
surfaces of type III AFP [39]. 
Determination of the surface concentration of AFPs on the ice crystal has similar 
difficulties. However, there have been some attempts to estimate AFP concentration at 
the ice crystal surface employing different methods such as fluorescence microscopy [77] 
or scanning tunneling microscopy [29]. Both studies indicated that AFPs bind to the ice 
crystal surface at monolayer or submonolayer coverage. In support of these data on 
adsorption onto ice surfaces, recent neutron reflection study also showed that type III 
AFP adsorbs as a single layer onto a hydrophilic SiO2 substrate [84]. Although the use of 
SiO2 as an ice crystal mimic is limited due to different crystal lattice dimensions, this 
does provide insight into the general adsorption behavior of the protein. 
 
1.8 Oligomerization domains 
 Oligomerization domains such as collagen triple helices and coiled coils make up 
the subunit assembly of a large number of proteins [85]. The alpha helical coiled coil is 
the most abundant subunit oligomerization motif found in proteins [86, 87]. Fibritin from 
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T4 bacteriophage is a triple helical coiled coil and it folds into this structure by the help 
of the foldon domain, which has been found to be necessary for the formation of the 
triple stranded coiled coil structures as a result of the mutagenesis studies [88, 89]. 
The addition of oligomerization domains to the functional proteins is very 
advantageous in most instances especially where the stabilization of the different 
domains is needed [88]. Oligomerization domains also introduce high binding strength by 
enforcing increased local concentration of the molecules that are attached to them [87, 
89].  
  
1.9 Bioconjugation 
 This section introduces a brief description of bioconjugation reactions, molecules 
and reagents that were used in this study. Bioconjugation is an emerging field in life 
sciences and has become an important tool in pharmaceutical and materials science [90-
93]. 
 Bioconjugation is a technique to form a novel molecule composed of one or more 
components (nano particles, proteins, polymers, antibodies, etc.) having functional 
groups that have compatible chemistries [94, 95]. Proteins are composed of amino acids 
that are polymerized together by forming peptide (amide) bonds. Amino acids form the 
backbone which constitutes central carbons and each central carbon is bound to a 
hydrogen molecule and a side chain. The sequence and the properties of the amino acids 
in the protein determine the structure and the function. Amino acids contain an amino 
group and a carboxyl group (Figure 1.2). There are 20 common amino acids found in 
nature, and they contain a specific side chain which determines the particular chemical 
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structure, charge, hydrophilicity, hydrogen bonding capability and reactivity [96]. Side 
chains do not participate in polypeptide formation reactions and are free to interact with 
their environment limited by the folded structure of the protein.   
 
 R 
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C 
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 H C H3N+ 
 
 
Figure 1.2. Amino acid structure. An amino acid consisting of a primary amine, a 
carboxylic acid group, and a side group. At physiological pH, the amine group is 
protonated and carries a positive charge and carboxylate is ionized and has a negative 
charge. 
 In order to successfully conjugate two molecules it is necessary to determine the 
chemical and physical characteristics of the molecules to be conjugated [96]. Isoforms of 
a molecule of interest can also be engineered to obtain a suitable functional group that 
has active sites which are reactive towards a crosslinker or a reagent that is tended to use 
in these reactions. In fact, in most cases this modification is necessary to create a 
compatible chemistry between the reagent and the target molecule. These reagents are 
generally commercially available and provide a solid support to almost every biological 
molecule such as peptides, proteins, oligonucleotides, lipids and organic compounds [96]. 
 The major challenge in these studies is the difficulty of introducing site specific 
functional groups to the reaction scheme [91, 95]. Proteins generally contain multiples of 
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the same functional group that is intended to be used in the conjugation reactions. This 
may not be a problem in some instances where it is known that some of these residues are 
buried in the protein’s folded structure and are not accessible for the reaction [97]. Hence, 
in order to overcome the difficulties related to the site specific bioconjugation, 
knowledge of the primary and secondary structures of the protein is required. 
Consequently, selecting less abundant amino acid as a target residue plays an important 
role in site directed bioconjugation. Among amino acids, tryptophan and cysteine 
residues are the most valuable targets in terms of their natural scarcity [98]. Dithiothreitol 
(DTT) can be used to disrupt disulfide bond formation, hence providing more cysteine 
residues available for bioconjugation reactions and preventing formation of unwanted 
chemical structures. However, care should be taken to account for biological activity of 
the molecule. Because, excessive addition of DTT into the reaction sometimes leads to 
disruption of the three dimensional structure of the protein and hence the possibility of 
the requirement of disulfide bonds for a specific biological activity should be considered 
[99]. Thiol groups present in cysteine residue are reactive towards several reagents such 
as maleimides and vinyl sulfones [100, 101]. The reaction of thiol groups at neutral pH 
produces irreversible thioester bonds which are stable under the reaction conditions 
[102]. Maleimides have double bonds which react with sulfhydryl groups to form stable 
thioether bonds. These molecules are generally used as heterobifunctional reagents which 
carry another functional group that is reactive towards another target molecule [100]. 
Heterobifunctional reagents are used in two-step reactions. Reagent is first reacted with 
one of the target molecules and then is reacted with the other. Having a reagent with two 
functional groups is advantageous because they are generally designed to have a linker 
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between the two functionalities which can be changed to improve reaction conditions 
such as solubility [103]. 
 The modification of carboxylic acid groups that are present in the carboxy-
terminus of the proteins is one of the most commonly used conjugation techniques [90]. 
Reactions of these groups with amines can be accomplished by introducing N-
hydroxysuccinimide (sulfo-NHS) ester which is water soluble and reactive towards a 
carboxylate in the presence of carbodiimide EDC [90, 104]. The water soluble 
carbodiimide can be used to form active ester bonds with the carboxylate groups using 
NHS. The addition of sulfo-NHS to EDC reactions is advantageous for increasing the 
solubility and stability of the active intermediate, which reacts with the target amine 
molecule [105].  
 
1.10 Scope of the thesis 
The ultimate goal of this work is to better understand ice crystal growth inhibition 
of AFPs so that more effective cryopreservative or ice slurry additives can be made. The 
work in this thesis uses thermal hysteresis measurements of different antifreeze protein 
constructs and relates these measurements to the kinetics and thermodynamics of 
adsorption. 
For this, several antifreeze protein constructs are designed to improve the thermal 
hysteresis activity. These constructs are engineered using site directed mutagenesis 
techniques and proteins are expressed in E.coli expression systems. Site directed 
bioconjugation techniques are used to create superior antifreeze molecules and are 
characterized using various methods such as thermal hysteresis measurements, 
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fluorescence microscopy, polyacrylamide gel electrophoresis, reverse phase and size 
exclusion HPLC and circular dichroism spectroscopy.  
In addition, Langmuir adsorption isotherm models are used to relate thermal 
hysteresis and surface coverage values of single-domain and two-domain type III AFP 
using previously published thermal hysteresis versus concentration data [61]. Surface 
coverage and binding energy are determined by fitting two independent thermal 
hysteresis data sets with the classical Langmuir isotherm and a modified isotherm for the 
one- and two-domain proteins, respectively. Such a comparison is possible because all of 
the domains have identical structures and should have equivalent binding energies. This 
study is also extended to trimers (three-domain AFPs) that are designed to improve the 
thermal hysteresis activity. We first describe the model systems with the governing 
equations, then derive the isotherms, and finally use these with our experimental data to 
relate thermal hysteresis with surface coverage. 
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CHAPTER II 
 
EXPERIMENTAL 
 
 This section introduces detailed information about the protein constructs that have 
been designed, prepared and characterized in this study. There are mainly two groups of 
AFPs which have distinct structural properties such as alpha helicity and size. One class 
of AFP that was studied in detail is type I AFP.  
We have produced T1D, which is an α-helical protein composed of five repeats of 
11 amino acids following a protocol given by Solomon et al., 1999 [106]. Another 
construct, T1N, which is an isoform of T1D was designed and produced by site directed 
mutagenesis for carboxy-terminus bioconjugation to a polyamine by removing the acidic 
residues in T1D. This reaction product is presented in Figure 2.1, where T1N is attached 
to the PAA, which is a linear chain polymer with amine groups attached to its backbone. 
A monomer making up PAA is also shown as an inset.   
In order to make trimers of T1D, we have used foldon domain, which keeps three 
domains in close proximity and folds them such that they form trimers [85, 88, 89]. This 
trimer sample, T1Dfoldon, was designed using a modified T1D gene that was attached to 
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the foldon domain with a linker between them. This construct is presented in Figure 3.1, 
where foldon domain forms a triple helix keeping the three T1D molecules as a trimer. 
 
 
 
 
 
 
 
 
Figure 2.1. Schematic diagram showing the T1Dfoldon. Foldon domain and T1N were 
produced from PDB IDs 1NAY [89] and 1WFA [36], using DeepView/Swiss-PdbViewer 
software program, respectively [50]. Red region represents the linker. 
 
Another protein construct was prepared using RD3, which is a two-domain type 
III AFP connected via 9-residue linker. Experiment sets were designed to isolate RD3N, 
which is the N-domain of the RD3, and this gene was modified such that it can be 
attached to the foldon domain having a linker. This construct was named as RD3Nfoldon 
and presented in Figure 2.2. 
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Figure 2.2. Schematic diagram showing the RD3Nfoldon. Foldon domain and N-domain 
RD3 were produced from PDB IDs 1NAY [89] and 1c8a [47], using DeepView/Swiss-
PdbViewer software program, respectively [50]. Red region represents the linker. 
 
Two more type III AFPs were prepared, which are named as RD3CCys and 
nfe8EGFPCys. RD3CCys is the C-domain RD3 with its linker. Cysteine residue was 
placed at the N-domain before the linker for site directed bioconjugation of this sample to 
a polyamine. nfe8EGFPCys is a single domain type III AFP and it was obtained using the 
gene for His-nfeAFP8-EGFP, which has His-tag (used aid protein purification process), 
nfeAFP8 (an isoform of type III AFP from Notched-fin eelpout, which lives off the north 
east coast of Japan) and EGFP (green fluorescence protein used to visualize where the 
protein binds to the ice crystal). The gene for His-nfeAFP8-EGFP was modified such that 
His-tag was removed and a cysteine residue was added to the C-terminal domain after 
EGFP for bioconjugation purposes. 
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In all procedures oligonucleotides (primers) were ordered from Invitrogen and the 
restriction endonucleases from New England Biolabs. Detailed descriptions of these 
procedures are given in the following sections. 
 
2.1 Synthesis and cloning of the genes 
 E. coli strain BL21 Star (from Invitrogen) was used as the cloning and the 
expression host strain. In all cloning experiments, pET20b was used as an expression 
plasmid (Novagen Inc.).  
The procedure for obtaining the gene for T1D (rAFP in their case) was previously 
described by Solomon et al., 1999 [106]. We have used a slightly modified version of 
their technique to obtain the sequence for T1D which was designed to have 5 repeats of 
the 11 amino acid repeat units from type I AFP winter flounder (Pseudopleuronecta 
americanus), 
MDTASDAAAAAALTAANAAAAAALTAANAAAAAALTAANAAAAAAL 
TAANAAAAAALTAR  
Briefly, four primers were used two of which included the major portion of the 
sequence (1000 and 2000) that was extended using the two other shorter primers 
(1001short and 2002short) according to the overlap extension technique.  
Short Primers (5´ to 3´): 
 
1001short: CCCCCCCCATATGGACACTGCCTCTGACG 
2002short: GCGCGGATCCTATTACCGTGCTGTCAAGGCC 
 
Template Primers (5´ to 3´): 
 
1000 (5´ to 3´): 
ACTGCCTCTGACGCCGCAGCTGCTGCAGCACTGACAGCGGCTAATGCTGCTGCAGCAGCA
GCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTC 
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2000 (5´ to 3´): 
CAAGGCCGCGGCCGCCGCCGCATTTGCGGCAGTCAGAGCAGCAGCTGCAGCTGCATTGGC
AGCGGTGAGTGCAGCTGCGGCTGCAGCG 
 
 
                ACTGCCTCTGACGCCGCAGCTGCTGCAGCACTGACAGCGGCTA 
CCCCCCCCATATGGACACTGCCTCTGACG 
 
ATGCTGCTGCAGCAGCAGCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTC 
                                  GCGACGTCGGCGTCGACGTGAGTGG 
 
CGACGGTTACGTCGACGTCGACGACGAGACTGACGGCGTTTACGCCGCCGCCGGCGCCG 
                                                        CCG  
GAAC 
GAACTGTCGTGCCATTATCCTAGGCGCG 
 
PCR amplifications were carried out in a 50 µl reaction volume using a thermal 
cycler (Thermo Electron Corp.) and reactions contained 0.01 µM template primers, 1.25 
µM short primers, nuclease free water and 1x PCR master mix obtained from Promega 
Corp. Amplified DNA was run on a 2% agarose gel in TAE buffer (40 mM Tris acetate, 
2 mM EDTA, pH 8.5) at 80 V.  
After agarose gel electrophoresis, DNA samples were purified using a gel 
extraction kit (Qiagen Inc.) and samples were eluted in double distilled water. The 
purified insert DNA and the pET20b expression vector were 10 fold over digested in a 
double digestion reaction using NdeI and BamHI restriction endonucleases. Digestion 
products were run on an agarose gel and purified (Promega), which were then used to be 
ligated. 1X Quick ligase buffer (New England Biolabs, Inc.) was used in five minute 
ligation reaction including approximately 50 ng of the vector DNA and approximately 10 
fold molar excess of the insert DNA. 10 µl of ligated products were transformed using 
BL21 Star (Invitrogen) competent cells on agar plates having LB (Lysogeny broth) 
medium and 100 µg ampicilin. After overnight transformation, colonies were selected 
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and plasmid DNA was purified from 5 ml overnight cultures using Qiagen Miniprep kit. 
Samples were then screened using PCR and sent for DNA sequencing. DNA sequencing 
of the T1D and T1N samples were carried out at the Cleveland State University 
Genomics Laboratory in the Department of Chemistry. Samples were sequenced using T7 
forward primer. One plasmid was designated as T1D. The DNA sequence for T1D is as 
follows: 
 
ATGGACACTGCCTCTGACGCCGCAGCTGCTGCAGCACTGACAGCGGCTAATGCTGCTGCA
GCAGCAGCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTCACCGCTGCCAATGCA
GCTGCAGCTGCTGCTCTGACTGCCGCAAATGCGGCGGCGGCCGCGGCCTTGACAGCACGG 
 
In order to conjugate this protein to a polyallyamine through its carboxy terminus, 
we have modified T1D by replacing the two acidic residues at the N-terminus. This 
modified protein was named as T1N and an analogous procedure was used to create the 
gene for producing T1N except that a slightly modified forward extension primer was 
designed to replace aspartic acid residues with asparagines.  
Short Primers (5´ to 3´): 
 
1001N:   CCCCCCCCATATGAACACTGCCTCTAACGCCGC 
2002short: GCGCGGATCCTATTACCGTGCTGTCAAGGCC 
 
Template Primers (5´ to 3´): 
 
1000 (5´ to 3´): 
ACTGCCTCTGACGCCGCAGCTGCTGCAGCACTGACAGCGGCTAATGCTGCTGCAGCAGCA
GCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTC 
 
2000 (5´ to 3´): 
CAAGGCCGCGGCCGCCGCCGCATTTGCGGCAGTCAGAGCAGCAGCTGCAGCTGCATTGGC
GCGGTGAGTGCAGCTGCGGCTGCAGCG A
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                ACTGCCTCTGACGCCGCAGCTGCTGCAGCACTGACAGCGGCTA 
CCCCCCCCATATGAACACTGCCTCTAACGCCGC 
 
ATGCTGCTGCAGCAGCAGCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTC 
                                  GCGACGTCGGCGTCGACGTGAGTGG 
 
CGACGGTTACGTCGACGTCGACGACGAGACTGACGGCGTTTACGCCGCCGCCGGCGCCG 
                                                        CCG  
GAAC 
GAACTGTCGTGCCATTATCCTAGGCGCG 
 
A similar procedure was used in PCR reactions and cloning the T1N gene, which 
is given as: 
 
ATGAACACTGCCTCTAACGCCGCAGCTGCTGCAGCACTGACAGCGGCTAATGCTGCTGCA
GCAGCAGCTTTGACTGCAGCGAACGCTGCAGCCGCAGCTGCACTCACCGCTGCCAATGCA
GCTGCAGCTGCTGCTCTGACTGCCGCAAATGCGGCGGCGGCCGCGGCCTTGACAGCACGG
TAATAG 
 
 Corresponding amino acid sequence for T1N is as follows (mutated sites are 
highlighted): 
MNTASNAAAAAALTAANAAAAAALTAANAAAAAALTAANAAAAAAL 
TAANAAAAAALTAR 
In order to incorporate T1D into the plasmid having a foldon domain and a linker, 
we have designed a system of procedures. T1D was modified in a 50 µl PCR reaction 
using two primers that were designed to add a SfiI recognition site at the 3´ end [107]. 
In the first step of the plasmid preparation, SfiI endonuclease recognition site was 
created and inserted into pET20b vector so that each time we wanted to incorporate a 
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new gene into the vector we would have to single digest the vector with SfiI 
endonuclease. In the below sequence, the inner piece (highlighted portion in the inner 
piece shows the SfiI recognition site) was annealed and ligated into a pET20b plasmid 
that had been double digested with NdeI and EcoRI endonucleases (cut sites are 
highlighted).  
 
CATATGAGCAAAGGGCCGGGCTGGCCGTGATAATTC 
GTATACTCGTTTCCCGGCCCGACCGGCACTATTAAG 
   
  NdeI        EcoRI 
 
In the annealing process, 0.8 µM forward and reverse primers were used in a 50 
µl reaction volume having 1X quick ligase buffer and nuclease free water (New England 
Biolabs, Inc.). Reaction mixture was heated at 94 oC for 5 minutes and then slowly 
cooled down to room temperature at a rate of 1 oC/ min using a thermocycler (Thermo 
Electron Corp.). The sample was directly ligated into a pET20b vector which was double 
digested with NdeI and EcoRI and purified by gel electrophoresis. 
 Foldon was also produced by annealing, using primers that were designed to form 
a foldon domain and have a SfiI recognition site. Annealed forward and reverse primer 
sequences are shown below. Highlighted ends represent the SfiI cut sites.  
 
   TGGCCGGGTTACATCCCGGAAGCTCCGCGTGACGGTCAGGCTTACGTTCGTAAAGA 
CCGACCGGCCCAATGTAGGGCCTTCGAGGCGCACTGCCAGTCCGAATGCAAGCATTTCT 
 
CGGTGAATGGGTTCTGCTGTCTACCTTCCTGTGATAAGGC 
GCCACTTACCCAAGACGACAGATGGAAGGACACTATT 
Annealed foldon primers were directly ligated to pET20b vector that was single 
digested with SfiI. After single digestion, sample was dephosphorylated using Antarctic 
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Phosphatase (New England Biolabs). In a 30 minute reaction at 37 oC, Antarctic 
Phosphatase helps to catalyze the removal of 5´ phosphate groups from DNA and it is 
used to prevent self ligation of the digested DNA. In the absence of the 5´ phosphoryl 
termini required by ligases, they cannot self-ligate. Hence, dephosphorylation is used to 
decrease the vector background in cloning. Digested and dephosphorylated vector was 
run on an agarose gel and then purified, which was then used to be ligated with annealed 
foldon gene. 
The next step was to produce a linker and incorporate it into the vector having a 
foldon domain and a SfiI recognition site. Forward and reverse linker primers were 
designed and annealed using the same procedure as described above. Annealed linker has 
a DNA sequence shown in below sequence with SfiI cut sites highlighted. 
 
        TGGCCGGACGGTACCACCTCCAAAGGC 
     CCGACCGGCCTGCCATGGTGGAGGTTT 
 
 In order to insert annealed linker, pET20b vector having a foldon domain and a 
SFiI cut site was single digested with SfiI. After single digestion, vector was 
dephosphorylated at 37 oC for 30 minutes and run on an agarose gel and then purified. 
Annealed linker was directly ligated into the vector.  
 The resulting portion of the vector pET20b (shown as a single piece of DNA from 
5´ to 3´) having a foldon domain, a linker and a SfiI recognition site is as follows:  
 
CATATGAGCAAAGGGCCGGGCTGGCCGGACGGTACCACCTCCAAAGGCTGGCCGGGTTAC
ATCCCGGAAGCTCCGCGTGACGGTCAGGCTTACGTTCGTAAAGACGGTGAATGGGTTCTG
CTGTCTACCTTCCTGTGATAAGGC 
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Sequence starts with the NdeI recognition site (first highlighted section in light 
gray) and continues with the SfiI recognition site (highlighted as dark gray), a linker 
which starts right after the SfiI recognition site and highlighted as light gray. The rest of 
the sequence corresponds to the foldon domain. 
In the following step, T1D was modified in order to include a SfiI recognition site 
at 3´ end of the gene. For this, two primers (shown below), T7 forward universal primer 
(New England Biolabs) and a designed Sfi typeI reverse were used in 50 μl PCR reaction 
as described above.  
T7 forward:           TAATACGACTCACTATAGGG 
Sfi typeI reverse: CCAAAAAAAGGCCAGCCCGGCCGTGCTGTCAAG 
 Modified T1D having a SfiI recognition site and the plasmid with foldon and 
linker were double digested with NdeI and SfiI endonucleases and separated by agarose 
gel electrophoresis and then purified. Purified insert and vector DNA were then ligated 
back together following the same procedures as described above. In all cases, after 
transformations were plated overnight, colonies were selected and plasmid DNA was 
purified from 5 ml overnight cultures using Qiagen Miniprep kit. Samples were then 
screened using PCR and sent for DNA sequencing. A sample of each was stored in -80 
oC freezer as a frozen stock (500 μl overnight culture in 500 μl 50% glycerol solution) for 
future use. DNA sequencing for all of the samples except T1D and T1N was carried out 
at the Cleveland Clinic Genomics Core. The amino acid sequence of the T1Dfoldon is as 
follows (the linker and the foldon domains are highlighted as light and dark gray, 
respectively): 
MDTASDAAAAAALTAANAAAAAALTAANAAAAAALTAANAAAAAALTAANAAAAA
ALTARPGWPDGTTSKGWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
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Type III AFP constructs were prepared using a two-domain type III AFP from 
antarctic eel pout (Rhigophila dearborni), which is named RD3 [47]. This gene was used 
as a template DNA in a PCR reaction with forward and reverse primers namely, T7 
Forward and Reverse RD3N SfiI. 
Reverse RD3N SfiI: CCCAAAGGCCAGCCCGGCCATTCGTAGTTTTT 
This reaction produces two bands; one at 595bp and the other at 295bp. Lower 
band was removed and purified from the agarose gel to get the N domain RD3 gene. 
However, the lower band needed to be amplified to obtain enough DNA for cloning. 
Hence, the lower piece was used as a template in another PCR reaction to amplify the 
DNA.  
 
The sequence of the lower band is: 
 
TAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAAC
TTTAAGAAGGAGATATACATATGAATAAAGCTTCCGTTGTTGCTAACCAGCTGATCCCGA
TCAACACCGCTCTGACCCTGATCATGATGAAAGCTGAAGTTGTTACCCCGATGGGTATCC
CGGCTGAAGAAATCCCGAACCTGGTTGGTATGCAGGTTAACCGTGCTGTTCCGCTGGGTA
CCACCCTGATGCCGGACATGGTTAAAAACTACGAATGGCCGGGCTGGCCTTTGGG 
 
 
After digesting the lower band with NdeI and SfiI endonucleases, DNA becomes: 
 
TATGAATAAAGCTTCCGTTGTTGCTAACCAGCTGATCCCGATCAACACCGCTCTGACCCT
GATCATGATGAAAGCTGAAGTTGTTACCCCGATGGGTATCCCGGCTGAAGAAATCCCGAA
CCTGGTTGGTATGCAGGTTAACCGTGCTGTTCCGCTGGGTACCACCCTGATGCCGGACAT
GGTTAAAAACTACGAATGGCCGGGC 
 
 The above piece was ligated to the plasmid having foldon, linker and SfiI 
recognition site that is double digested with NdeI and SfiI endonucleases. 
 The resulting sequence for Rd3Nfoldon is as follows (the linker and the foldon 
domains are highlighted as light and dark gray, respectively): 
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MNKASVVANQLIPINTALTLIMMKAEVVTPMGIPAEEIPNLVGMQVNRAVPLGTTLMPDM
VKNYEWPGWPDGTTSKGWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
 Another type III AFP construct, RD3CCys was produced similarly from the RD3 
gene. RD3 was used as a template in a 50 μl PCR reaction with forward and reverse 
primers, RD3CCysForward and Reverse 20b, respectively.  
 
RD3CCysForward: GGATATCATATGTGCACCACCTCCCCGGGTCTG 
Reverse 20b: AATTGCAAGCTTGTCGACG 
 
 After the PCR reaction, both insert and the vector (pET20b) were double digested 
using BamHI and NdeI endonucleases and then purified. These pieces were ligated to 
each other to form RD3CCys, which has a DNA sequence of: 
CATATGTGCACCACCTCCCCGGGTCTGAAATCCGTTGTTGCTAACCAGCTGATCCCGATC
AACACCGCTCTGACCCTGGTTATGATGAAAGCTGAAGAAGTTTCCCCGAAAGGTATCCCG
TCCGAAGAAATCTCCAAACTGGTTGGTATGCAGGTTAACCGTGCTGTTTACCTGGACCAG
ACCCTGATGCCGGACATGGTTAAAAACTACGAATAG 
  
 The corresponding amino acid sequence for RD3CCys is given as: 
CTTSPGLKSVVANQLIPINTALTLVMMKAEEVSPKGIPSEEISKLVGMQVNRAVYLDQTL
MPDMVKNYE 
Dark gray highlighted C represents the cysteine residue on the N-terminus, while 
the inner light gray highlighted region is the linker designed to have a space between the 
protein and the cysteine residue. The rest of the sequence is the C-domain of the RD3. 
One other construct was nfe8EGFPCys, which is an isoform of type III AFP and 
it was obtained using the gene for His-nfeAFP8-EGFP (His-tag, nfeAFP8 and EGFP) 
[108]. Green fluorescence protein is used to visualize where the protein binds to the ice 
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crystal. The gene for His-nfeAFP8-EGFP was modified such that His-tag was removed 
and a cysteine residue was added to the C-terminal domain after EGFP for 
bioconjugation purposes.  
The original DNA sequence for nfe8EGFPCys is as follows (His-tag region is 
highlighted in the below sequence): 
CATATGCACCACCACCACCACCACAACCAGGCGTCCGTGGTGGCCAACCAGC
TGATCCCCATAAATACTGCCCTGACTCTGGTGATGATGAGGGCGGAGGTGGT
CACCCCAATGGGCATCCCCGCCGTGGACATTCCCCGATTAGTCTCAATGCAA
GTGAACAGGGCAGTGCCGTTGGGCACAACCCTCATGCCAGAGATGGTGAAAG
GGTACACCCCGGCTGAATTCGAAATCACTAGTGAATTCGATATCAAGCTTATC
GATACCGTCGACCTCGACATGTCTAAAGGTGAAGAATTATTCACTGGTGTTGT
CCCAATTTTGGTTGAATTAGATGGTGATGTTAATGGTCACAAATTTTCTGTCT
CCGGTGAAGGTGAAGGTGATGCTACTTACGGTAAATTGACCTTAAAATTTATT
TGTACTACTGGTAAATTGCCAGTTCCATGGCCAACCTTAGTCACTACTTTCGG
TTATGGTGTTCAATGTTTTGCGAGATACCCAGATCATATGAAACAACATGACT
TTTTCAAGTCTGCCATGCCAGAAGGTTATGTTCAAGAAAGAACTATTTTTTTC
AAAGATGACGGTAACTACAAGACCAGAGCTGAAGTCAAGTTTGAAGGTGAT
ACCTTAGTTAATAGAATCGAATTAAAAGGTATTGATTTTAAAGAAGATGGTA
ACATTTTAGGTCACAAATTGGAATACAACTATAACTCTCACAATGTTTACATC
ATGGCTGACAAACAAAAGATGGTATCAAAGTTAACTTCAAATTAGACACAAC
ATTGAAGATGGTTCTGTTCAATTAGCTGACCATTATCAACAAAATACTCCAAT
TGGTGATGGTCCAGTCTTGTTACCAGACAACCATTACTTATCCACTCATCTGC
CTTATCCAAAGATCCAAACAAAAGAGAGACACATGGTCTTGTAAAATTTGTT
ACTGCTGCTGGTATTACCATTGGTATGGATGAATTGTACAAATAGTCGAGAAT
CCATCACACTGGCGGCCGCTCGAGCCCACCACACCACCTCTGAGATCTGCTG
CTACTAAGCCCGAAGGAATTGAGTGGCTGCTGCACGTTAACAATACAGCTAC
CCCTTGGGCCTCAAACGTTTTGAGGGTTTTGTTAAGGCGTATTATTCGATTGT
CTATGGACACCTCTTCGCCCTTAATCCGCGGTGAGCGTTCACCACTTC 
 
 The forward and reverse primers were designed to remove the His-tag.  
AseI nfe8EGFP Forward: GGGAAAATTAATGAACCAGGCGTCCGTGGTG 
 
BamHI nfe8EGFP Cys Reverse: CCCCGGATCCCTAGCATTTGTACAATTCATCC 
 
After performing PCR reaction with forward and reverse primers, the DNA of 
interest became as follows (AseI, NdeI and BamHI recognition sites were highlighted in 
order):  
 31
 
GGGAAAATTAATGAACCAGGCGTCCGTGGTGGCCAACCAGCTGATCCCCATAAATACTGC
CCTGACTCTGGTGATGATGAGGGCGGAGGTGGTCACCCCAATGGGCATCCCCGCCGTGGA
CATTCCCCGATTAGTCTCAATGCAAGTGAACAGGGCAGTGCCGTTGGGCACAACCCTCAT
GCCAGAGATGGTGAAAGGGTACACCCCGGCTGAATTCGAAATCACTAGTGAATTCGATAT
CAAGCTTATCGATACCGTCGACCTCGACATGTCTAAAGGTGAAGAATTATTCACTGGTGT
TGTCCCAATTTTGGTTGAATTAGATGGTGATGTTAATGGTCACAAATTTTCTGTCTCCGG
TGAAGGTGAAGGTGATGCTACTTACGGTAAATTGACCTTAAAATTTATTTGTACTACTGG
TAAATTGCCAGTTCCATGGCCAACCTTAGTCACTACTTTCGGTTATGGTGTTCAATGTTT
TGCGAGATACCCAGATCATATGAAACAACATGACTTTTTCAAGTCTGCCATGCCAGAAGG
TTATGTTCAAGAAAGAACTATTTTTTTCAAAGATGACGGTAACTACAAGACCAGAGCTGA
AGTCAAGTTTGAAGGTGATACCTTAGTTAATAGAATCGAATTAAAAGGTATTGATTTTAA
AGAAGATGGTAACATTTTAGGTCACAAATTGGAATACAACTATAACTCTCACAATGTTTA
CATCATGGCTGACAAACAAAAGAATGGTATCAAAGTTAACTTCAAAATTAGACACAACAT
TGAAGATGGTTCTGTTCAATTAGCTGACCATTATCAACAAAATACTCCAATTGGTGATGG
TCCAGTCTTGTTACCAGACAACCATTACTTATCCACTCAATCTGCCTTATCCAAAGATCC
AAACGAAAAGAGAGACCACATGGTCTTGTTAGAATTTGTTACTGCTGCTGGTATTACCCA
TGGTATGGATGAATTGTACAAATGCTAGGGATCCGGGG 
 
The above DNA was double digested with AseI and BamHI and ligated to the 
pET20b vector, which was double digested with NdeI and BamHI. Since, there is a NdeI 
recognition site in the middle of the sequence, we have chosen another endonuclease, 
AseI to digest 5´ end of the insert DNA. This is possible because, NdeI and AseI have 
common overhangs but different recognition sites. Purified insert and vector were then 
ligated back together to form nfe8EGFPCys, which has an amino acid sequence as 
follows: 
MNQASVVANQLIPINTALTLVMMRAEVVTPMGIPAVDIPRLVSMQVNRAVPLGTTLMPEM
VKGYTPAEFEITSEFDIKLIDTVDLDMSKGEELFTGVVPILVELDGDVNGHKFSVSGEGE
GDATYGKLTLKFICTTGKLPVPWPTLVTTFGYGVQCFARYPDHMKQHDFFKSAMPEGYVQ
ERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMA
DKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEK
RDHMVLLEFVTAAGITHGMDELYKC 
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The above sequence for nfe8EGFPCys starts with nfe8 (first highlighted section) 
at the N-terminus followed by the green fluorescence protein (middle highlighted section) 
and a cysteine residue (highlighted as dark gray) at the C-terminus. 
 
2.2 Protein expression and purification 
Overnight cultures of T1D and T1N in 5 ml LB medium were used to inoculate 
1L cultures having 100 µl ampicilin. Samples were induced with isopropyl--D-
thiogalactopyranoside (IPTG) (Thermo Fisher Scientific Inc.) after optical cell density 
has reached a value of 0.6 that was measured using a UV spectrophotometer (Thermo 
Electron Corp.) at 600 nm. Induced samples were shaken in an incubator at 37 oC for 6 
hours. Time course of the 1 ml samples that were taken before induction and every hour 
after induction was monitored by polyacrylamide gel electrophoresis (10-20 % tris-
glycine). Samples were centrifuged at 14000 rpm using a microcentrifuge and 
supernatant was discarded. Pellets were resuspended in 100 µl BPER (Pierce) and 
centrifuged again to separate soluble and insoluble fractions. 20 µl samples were run on 
the Tris-glycine gel at 80 Volts for two hours. Then it was stained using GelCode Blue 
staining reagent (Pierce) and then destained according to the protocol given in the 
manufacturer’s manual. It was observed that both proteins were primarily in the insoluble 
fractions. 
T1D and T1N samples were purified using ethanolic extraction according to the 
protocol given in Solomon and Appel, and dialyzed against 100 mM ammonium 
bicarbonate using 1000 Da cutoff membrane and then lyophilized for further experiments 
[106]. 
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The other proteins were expressed as discussed above and purified using a 
detergent, BPER (Pierce) following the manufacturer’s protocol followed by denaturation 
in 6 M Guanidine hydrochloride. Samples were refolded in buffer (50 mM K2PO4 and 
100 mM NaCl) for 3 days at 4oC. A detailed protein purification protocol is given in 
Appendix (A5). 
Reverse phase HPLC was run using Shimadzu HPLC system for T1D and T1N to 
ensure the purity of the proteins. Two different solutions (solution A: 950 ml double 
distilled water, 50 ml acetonitrile (HPLC grade, Sigma-Aldrich), 1 ml TFA and solution 
B: 600 ml acetonitrile, 300 ml isopropanol, 100 ml double distilled water, 0.75 ml TFA) 
were pumped to the C18 column (150x10 mm) (Restek) with 0.5% gradient of 85% to 
100% solution B between 6 and 36 minutes followed by 100% solution B for an 
additional 5 minutes to ensure that the proteins were eluted from the column.  
 
2.3 Molecular weight determination 
Molecular weight of the samples was determined by mass spectroscopy as 5108.6 
and 5105.6 Da for T1D and T1N, respectively. These results were in accordance with the 
weights calculated from the primary sequence. Samples were analyzed at the University 
of Oklahoma Health Sciences Center (Molecular Biology Proteomics Facility). The size 
of the other samples was determined using polyacrylamide gel electrophoresis.  
 
2.4 Protein concentration determination 
Concentration of the concentrated master solutions of T1D and T1N were 
determined by amino acid analysis. Highly hydrophobic, lyophilized protein was 
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resuspended in 10% acetic acid and dialyzed against 0.4% acetic acid and 30 mM 
ammonium bicarbonate (pH 4.6) for buffer exchange. Samples were analyzed at the 
University of Oklahoma Health Sciences Center (Molecular Biology Proteomics 
Facility). Both protein samples, containing 100 µl of approximately 1mg/ml solution of 
TID or TIN, were transferred to hydrolysis tubes and then the sample container vials 
were rinsed with 80 µl of 33% acetonitrile and then 80 µl of 30% acetic acid. The 
samples were Speed-Vac dried, 6 N HCl was added and the tubes were vacuum sealed 
and hydrolyzed at 110oC for 20 hrs. Post-hydrolysis, 50 nanomoles of -(2-Thienyl)-DL-
Alanine internal standard was added and the hydrolysate was vacuum-centrifuged to 
dryness. The hydrolysate was redissolved in 200 µl of 0.01 N HCl and passed through a 
0.45 µm filter with centrifugation. 
For the other proteins, concentrations were determined by calculating the molar 
extinction coefficients by following the procedure given by Gill and Hippel [109]. 
Briefly, the molar extinction coefficient of a denatured protein in 6M guanidine 
hydrochloride (GdnHCl) is calculated by using the number of the absorbing residues in 
the protein amino acid sequence. The model compounds that have a distinctive 
absorbance at a specific UV wavelength (276-282 nm) are tryptophan, tyrosine and 
cysteine for which the molar extinction coefficients have been measured previously 
[109]. The molar extinction coefficient of a denatured protein in (M.s)-1 is given by: 
CysMTrpMTyrMHClGdnM cba ,,,.,       (2.1) 
In equation 2.1, TyrM , , TrpM , , and CysM ,  are the molar extinction coefficients of 
tyrosine, tryptophan, and cysteine, respectively. The coefficients a, b, and c are the 
number of each residue per protein molecule.  
 35
In order to determine the molar extinction coefficient of the native protein, native 
and denatured (in 6M GdnHCl) protein solutions with the same concentrations were 
prepared. Then, the concentration of the denatured protein, which was experimentally the 
same as the native protein was calculated using the UV absorbance measured at 280 nm 
according to equation 2.2. 
HClGdnMHClGdnden AbsC .,. /       (2.2) 
Where,  is the UV absorbance measured for the denatured protein at 
280 nm. Equation 2.3, which is similar to the equation 2.2 is also valid for the native 
protein: 
HClGdnAbs .
natMnatnat AbsC ,/        (2.3) 
In the final step, the molar extinction coefficient of the native protein was 
calculated by equating the concentration terms in the above equations. The resulting 
equation becomes (equation 2.4): 
)/())(( ..,, HClGdnHClGdnMnatnatM AbsAbs       (2.4) 
 This procedure was repeated for five times for each protein at each concentration 
and a calibration curve was constructed to ensure the linearity of the absorbance values 
with respect to concentration.  
 
2.5 Antifreeze protein/polymer bioconjugates 
In the T1N/polyallylamine reaction, 5 µl polyallylamine (Sigma-Aldrich) (20 w% 
in water) was mixed with 24 µl EDC (1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride) (Sigma-Aldrich) and 10.9 µl sulfo-NHS (n-hydroxysulfosuccinimide) 
(Sigma-Aldrich) in 300 µl 0.4% acetic acid, 30 mM ammonium bicarbonate [96]. T1N 
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(0.3 mM, which is approximately 13 molar excess of the polymer) was added to the 
reaction mixture in a round bottom volumetric flask and stirred using a small magnet for 
2 hours at room temperature. A schematic diagram of the reaction product is given in 
Figure 2.3. After reaction is completed, unreacted impurities were removed by dialysis 
using 3500 MW cutoff Spectra/Por dialysis membrane.  
 
 
 
 
 
 
 
 
Figure 2.3. Schematic diagram representing T1N/PAA reaction product. T1N was 
produced from PDB ID 1WFA [36], using DeepView/Swiss-PdbViewer software 
program [50]. PAA (17 kDa) was produced using PyMOL version 0.99. 
 
RD3CCys and nfe8EGFPCys were also reacted to the polyallylamine but using a 
different reaction scheme in a two step process. These molecules were designed to have 
only one cysteine residue at either 5´ or 3´ end for site directed conjugation. NHS-PEG6-
Maleimide crosslinker (Thermo Scientific) was used in the conjugation reactions (Figure 
2.4). Polyethylene glycol linker between heterobifunctional linker is used to improve 
solubility of the conjugated product [96]. 
 37
Figure 2.4. NHS-PEG6-Maleimide (N-hydroxysuccinimidyl-([N- 
maleimidopropionamido]-hexaethyleneglycol) ester) produced using PyMOL 
version 0.99. 
 
First, 1 mM crosslinker was reacted with PAA in 10 fold molar excess. 8.5 
μl PAA (20 w% in water) and 4 μl 250 mM crosslinker were mixed in 1 ml PBS 
(phosphate buffered saline) and 2 mM EDTA, pH 7.2 in a round bottom flask and 
incubated at room temperature for 30 minutes by stirring. EDTA (calcium chelator) 
was added to the solution to prevent metal catalyzed disulfide bond formation. 
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Figure 2.5. Schematic representation of RD3CCys/PAA (left) and 
nfe8EGFPCys/PAA (right) reactions. EGFP and C-domain RD3 were produced 
from PDB IDs 2oky [110] and 1c8a [47], using DeepView/Swiss-PdbViewer 
software program, respectively [50]. A short segment of PAA was produced using 
PyMOL version 0.99. 
 
In a separate vessel, 5 mM Tris[2-carboxyethyl] phosphine (TCEP from Thermo 
Scientific) was added to the RD3Ccys and nfe8EGFPCys protein solutions to prevent the 
formation of dimers through disulfide bonds between cysteine residues. Protein samples 
were reacted with TCEP for reducing disulfide bonds for 1 hour and then dialyzed against 
the conjugation buffer (PBS, 2 mM EDTA, pH 7.2).  
 After the first reaction was completed, 200 μl of reacted PAA and 0.4 mM protein 
solution were mixed in the same conjugation buffer (1 ml total solution volume) and 
reacted at room temperature for 2 hours and then stored at 4oC.  
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2.6 Size exclusion HPLC 
A 500 µl aliquot of the reaction mixture was loaded to the 20 ml Bio-scale size 
exclusion column (Bio-Rad Laboratories, Inc.) filled with Toyopearl HW-55F resin 
(Tosoh Corp.). Column was filled with the resin according to the manufacturers’ 
instructions. Reaction buffer solution was pumped to the HPLC (Shimadzu) column in 
the down-flow mode at a flow rate of 1 ml/min and UV absorbance values were recorded 
at 230 and 280 nm at the same time reaction mixture injected to the column. Samples 
were collected from the column outlet at every minute to be analyzed later.  
 
2.7 Thermal hysteresis experiments 
The interaction of AFPs with the ice crystal results in thermal hysteresis, which is 
the difference between freezing and melting temperatures. Thermal hysteresis activity 
was measured using a home made nanoliter osmometer (Laboratory of Art Heuer at 
CWRU) attached to an optical microscope (Olympus) as previously described (Figure 
2.6) [73]. Briefly, a single drop of protein solution was suspended in oil. The droplet was 
flash frozen at around -40 oC and, upon increasing the temperature to the melting point, 
was thawed slowly (approximately 0.2 oC/min) until a single ice crystal was obtained. 
After obtaining a single ice crystal, solution was cooled at a rate of 0.01 oC/min. The 
temperature at which the crystal grows was recorded as the freezing temperature. The 
difference between these two temperatures was taken as the thermal hysteresis [22, 43, 
60]. Morphological changes of the ice crystal structure in the presence of AFPs were also 
investigated using optical microscopy and a digital camera. 
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A single ice crystal (15 ± 0.2 µm) 
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Cooling water
 
(A)   (B)   (C) 
Figure 2.6.  (A) General view of the nanoliter osmometer, (B) Top view of the 
aluminum sample holder, (C) Side view of the one hole of the sample holder 
including oil and sample in it. 
 
 The sample holder has 5 holes which are 600 µm in diameter (Figure 2.6). A 
droplet of immersion oil (Cargill, type B from Thermo Fisher Scientific) was placed into 
one of the holes of the nanoliter osmometer using a custom-built injector composed of a 
glass pipette, a small tubing, a glass Pasteur pipette and a bulb. Glass pipette was made 
using a pipette puller by optimizing the parameters such as temperature and pulling speed 
in order to create a tip around 10 μm in diameter which is the appropriate tip size for this 
system. Approximately, 14 nl of the protein solution, which corresponds to a spherical 
droplet size of 300 μm in diameter was injected into the immersion oil. It is very 
important that the solution is not contacted with the aluminum walls of the sample holder 
and is not exposed to air to prevent any possible ice crystal nucleation. Automatic 
nanoliter injector (Drummond Scientific) with a 3D manipulator was used along with the 
glass micropipettes in order to inject the protein sample. Automatic injector provides 
accurate and reproducible injection volumes. Glass micropipettes were filled with 
 41
immersion oil to provide even more consistency in the sample size. Since, oil is 
incompressible, the automated plunger moving towards the tip of the glass micropipette 
only works to inject the sample of interest without compressing the air inside the pipette.  
 The other major issue is to prevent the condensation occurring on the sample 
stage caused by the humid air in the laboratory while cooling. This was prevented using a 
setup including a pump connected to desiccant filled column to produce dry air being sent 
onto the sample holder. The microscope was sealed from the environment using a plastic 
bag to keep the dry air inside. 
 
2.8 Circular dichroism spectroscopy studies 
 CD spectra were measured using a circular dichroism spectrometer (Aviv) for 
purified T1D, T1Dfoldon and RD3Nfoldon samples in the Physiology and Biophysics 
Department at Case Western Reserve University. Samples were analyzed in single runs at 
25 oC between 190 to 250 nm. -helicity of the T1D and the characteristic folding of the 
foldon constructs were investigated. 
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CHAPTER III 
 
RESULTS AND DISCUSSION 
 
3.1 Expression and purification of the proteins 
This section introduces the results and discussion regarding the expression 
and purification of the recombinant type I and type III antifreeze proteins used in 
this study.  
 
3.1.1 Expression and purification of T1D and T1N 
T1D was designed to contain five repeats of the 11 amino acid repeat units 
from winter flounder [106]. The sequence of the gene to code for T1D was designed 
to form long synthetic oligonucleotides in the correct register during PCR reactions. 
Since this gene includes repetitive units, special care must be taken when designing 
the primers to prevent misannealing in PCR reactions. The four oligonucleotides 
were amplified by using an overlap extension technique. After PCR amplifications, 
the gene was purified using agarose gel electrophoresis and then the gel piece was 
purified. In the following step, the gene was successfully double digested using 
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endonucleases that have cut sites at both ends of the gene. This sample was cloned 
into the double digested and purified expression vector, pET20b and then 
transformed into the E.Coli host strain. After overnight transformation, colonies 
grown on the agar plates were selected and expressed overnight in liquid cell culture 
medium (LB). Cells grown in the cell culture were collected by centrifugation and 
their gene was extracted (Miniprep, Qaigen). These DNA samples were tested in 
additional PCR reactions and successful samples were sequenced. One plasmid 
having the correct sequence was designated as T1D.  
Time course of the samples (before induction and every hour after induction) for 
both soluble and insoluble fractions were collected and monitored by polyacrylamide gel 
electrophoresis in order to determine the optimal expression and purification strategy. 
In Figure 3.1, six hour time course of the bacterial protein expression is presented. 
1 ml samples were taken during the time course and cells were separated by 
centrifugation. Pellets were then resuspended in 100 µl BPER (Pierce) and centrifuged at 
14000 rpm using a table top centrifuge. Supernatant represents the soluble fraction while 
the pellets are the insoluble fractions. Insoluble fractions were resuspended again in 100 
µl BPER solution for electrophoresis. 20 µl samples were run on the tris-tricine gel at a 
constant voltage (80 V) for two hours [111]. SDS page was then stained using GelCode 
Blue staining reagent (Pierce) and destained according to the protocol given in the 
manufacturer’s manual. 
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Figure 3.1. Tris-Tricine gel of the time course of T1D expression. Lanes 1 and 16 are the 
molecular weight markers. Lanes 2-7 are the insoluble fractions of 6 hour postinduction 
period from 6 hours to 1 hour, respectively. Lane 8 is the insoluble fraction preinduction 
control. Similarly, lanes 9-14 are the soluble fractions of 6 hour postinduction period and 
Lane 15 is the soluble fraction preinduction control. 
 
It is clearly seen from Figure 3.1 that T1D is accumulated only in the insoluble 
fractions. In this case, proteins form aggregates and they are present in inclusion bodies. 
It is seen that T1D expression starts after induction and expression level increases over a 
period of 3 hours. After 3 hours T1D expression remains stable up to 6 hours. When 
compared to the molecular weight markers, the size of T1D is approximately 5000 kDa 
as expected. It was also determined from the mass spectroscopy data that the actual size 
of T1D is 5108.6 g/mol. 
For site directed bioconjugation purposes, an isoform of T1D was designed. In 
order to conjugate this protein to a polyallyamine through its carboxy terminus, T1D was 
modified by replacing the two acidic residues at the N-terminus. This modified protein 
was named as T1N and a similar procedure was used to create the gene for producing 
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T1N except that a slightly modified forward extension primer was designed to replace 
aspartic acid residues with asparagines. After successfully obtaining the T1N gene 
following the similar protocol as in the case of T1D, 1L culture of T1N was inoculated 
with 5 ml overnight culture and protein expression time course was monitored. 
  
 
3.5 kDa 
1   2   3  4   5   6   7  8   9  10 11 12 13 14 15 16 
 
 
 
T1N 10 kDa  
 
Figure 3.2. Tris-tricine gel of the time course of T1N expression. Lanes 1 and 16 are the 
molecular weight markers. Lane 2 is the soluble fraction preinduction control. Lanes 3-8 
are the soluble fractions of 6 hour postinduction period from 1 hour to 6 hours, 
respectively. Similarly, lane 9 is the insoluble fraction preinduction control and lanes 10-
15 are the insoluble fractions of 6 hour postinduction period. 
 
In Figure 3.2, six hour time course of the bacterial protein expression is presented. 
1 ml samples were taken during the time course and cells were separated by 
centrifugation. It is clearly seen from Figure 3.2 that T1N is also accumulated only in the 
insoluble fractions. T1N expression starts after induction and expression level increases 
over a period of 3 hours. After 3 hours T1N expression remains stable up to 6 hours. The 
size of this protein can be compared with the molecular weight markers. It is seen that the 
 46
size of the T1N is also approximately 5000 kDa. It was determined from the mass 
spectroscopy analysis that the actual size of the T1N is 5105.6 g/mol as expected.  
After expressing T1D and T1N, samples were purified using ethanolic extraction. 
This was possible because the samples were soluble in ethanol. For this, cell pellets were 
solubilized in ethanol and heated at 75 oC. Since the proteins are soluble in ethanol, 
insoluble proteins could be removed by centrifugation. Protein solutions were then mixed 
with acetone for precipitation. Precipitated protein was recovered by centrifugation and 
and solubilized. Final solutions were dialyzed against 10 mM ammonium bicarbonate 
using 1000 Da cutoff membrane and then lyophilized. Details of this procedure is given 
in Appendix (A.5).  
Purified samples were run on the tris-tricine polyacrylamide gel. It is clearly seen 
from Figure 3.3 that T1D and T1N samples were successfully purified as there are no 
additional protein bands visible on the gel.   
 1 2 3 4
 
 
 
 
 10 kDa 
 
Figure 3.3. Tris-tricine gel of the purified T1D and T1N. Lane 4 is the molecular weight 
marker. Lane 3 is the T1N sample before purification and lanes 1 and 2 are the purified 
T1D and T1N, respectively. 
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 Purity of the samples was also confirmed by reverse phase HPLC (Figure 3.4). 
Two different solutions having different levels of hydrophobicities (solution A: 950 ml 
double distilled water, 50 ml acetonitrile (HPLC grade, Sigma-Aldrich), 1 ml TFA and 
solution B: 600 ml acetonitrile, 300 ml isopropanol, 100 ml double distilled water, 0.75 
ml TFA) were pumped to the C18 column (150x10 mm) (Restek) with 0.5% gradient of 
85% to 100% solution B between 6 and 36 minutes followed by 100% solution B for an 
additional 5 minutes to ensure that the proteins were eluted from the column.   
 
A
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Figure 3.4. Reverse phase HPLC results for T1D (black) and T1N (red).  
 
 Since T1D and T1N are highly hydrophobic proteins containing 70% alanine 
residues in their amino acid sequence, they have a strong interaction with the 
hydrophobic C18 column. Type I AFPs longer than the HPLC6 have shown to exhibit 
significant interaction with the C18 columns [112]. Hence, it requires using high 
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concentration of hydrophobic solvents to elute the proteins from the column. In Figure 
3.4, the peak around 10 minutes corresponds to acetonitrile, while the proteins started to 
be eluted from the column at 36 minutes. Since there is no additional peaks observed in 
the chromatogram, no further purification was performed.  
  
3.1.2 Expression and purification of T1Dfoldon and RD3Nfoldon 
T1D gene was used to prepare a trimer (T1Dfoldon) of this protein using foldon 
domain. Foldon domain from bacteriophage T4 fibritin is known to form three stranded 
triple helix which allowed us to make a trimer of -helical T1D. To facilitate the folding 
of the protein, a 9 residue linker was designed and used to connect the foldon domain to 
the carboxy-terminus of T1D. This was a multi-step process involving point mutations 
and the preparation of the individual components of the plasmid. After successful 
preparation of the gene, T1Dfoldon was expressed in 1L culture. It was determined that 
the protein goes into the insoluble fractions as in the case of its precessors.  
A time course for the expression of T1Dfoldon was monitored using tris-glycine 
gel electrophoresis for optimal expression. As can be seen from Figure 3.5 that 
recombinant T1Dfoldon expression started after induction and no increase in the level of 
expression was observed after 2 hours. From the DNA sequences the molecular weight of 
this protein was calculated as 9525.6 g/mol, which seems to be in good agreement with 
the gel electrophoresis. 
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Figure 3.5. Tris-glycine gel of the T1Dfoldon. Lane 5 is the molecular weight marker. 
Lane 1 is the preinduction control and lanes 2-4 are the postinduction samples collected 
every 2 hours.  
 
T1Dfoldon was purified from the inclusion bodies using BPER bacterial protein 
extraction reagent (Pierce) following the general protein extraction and purification 
protocol given in Appendix. In the final stage of the purification, T1Dfoldon in the pellet 
form was solubilized using a denaturant, Guanidine hydrochloride (6M) and then 
refolded in PBS (phosphate buffered saline) for 3 days at 4 oC to ensure complete 
refolding of the protein. Refolded protein was then concentrated using a concentrator 
(ICON, Pierce) until it starts precipitating, which indicates that the solubility limit is 
reached. A small fraction from this purified sample was then run on the tris-glycine gel to 
confirm its purity.  
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Figure 3.6. Tris-glycine gel of the purified T1Dfoldon. Lane 1 is the molecular weight 
marker. Lanes 2 and 3 are the purified T1Dfoldon samples with and without boiling in 
SDS, respectively. 
  
 In polyacrylamide gel electrophoresis, samples are boiled at 100 oC for 5 minutes 
in sodium dodecyl sulfate (SDS) for complete denaturation of the protein. As a control 
purified T1Dfoldon sample was injected into the gel without boiling. It seems from 
Figure 3.6 that the sample is still in the denatured monomer form even without boiling 
prior to injection. This might be the indication of misfolding the T1Dfoldon as it was 
proved by further characterization studies explained in the following section. The sample 
seems to be pure enough eliminating the need of further purification.  
 RD3Nfoldon gene was successfully created as described in T1Dfoldon 
purification. 1 L culture of RD3Nfoldon was expressed and a time course showing the 
level of expression was monitored by tris-glycine gel electrophoresis.  
 51
As can be seen from Figure 3.7 that RD3Nfoldon expression started after 
induction and no significant increase in the level of expression was observed after 2 
hours. Molecular weight of this protein was calculated from the DNA sequence as 
11640.6 g/mol, which seems to be in good agreement with the gel electrophoresis. 
 
 
1    2    3   4    5  
 
 
 
 
 
 
 
 
 
 12 kDa 
 
 
 
Figure 3.7. Tris-glycine gel of the RD3Nfoldon. Lane 5 is the molecular weight marker. 
Lane 1 is the preinduction control. Lanes 2-5 are the postinduction samples collected 
every 2 hours. 
 
 After 6 hour expression RD3Nfoldon was purified and concentrated following the 
same procedure as in the case of T1Dfoldon. In order to test the folding of the 
RD3Nfoldon, purified samples were run on tris-glycine gel by heating the sample at 
different temperatures prior to injection. Also, the effect of exposure time of this sample 
at 100 oC was investigated.   
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 It is seen in Figure 3.8 that RD3Nfoldon sample that was injected without heating 
showed more than 90% folding indicated by a darker band at around 30 kDa level which 
is three times more mass than the monomer. Upon heating at 50 oC, trimer to monomer 
ratio decreased to approximately 50%. Increasing the temperature to 60 oC led the 
formation of almost 90% monomer in denatured form whereas about 10% of the sample 
remained folded. For the samples that were heated to 70, 80 and 90 oC, complete 
disruption of the folding was observed. These results are consistent with the circular 
dichroism (CD) spectroscopy analysis data for foldon samples heated from 40 to 90 oC 
[88]. In their study, the stability of foldon was assessed by thermal unfolding profiles 
recorded by CD at the characteristic wavelength for the foldon, 228 nm and the transition 
temperature was found to be around 60 oC.  
Only the sample heated for 30 seconds at 100 oC (lane 7 in Figure 3.8) showed 
some degree of folding, however increased exposure time completely disrupted the 
stability of the foldon domain. 
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Figure 3.8. Tris-glycine gel of the purified RD3Nfoldon. Lane 1 is the molecular weight 
marker. Lanes: 1) sample injected without heating. 2-6) sample injected after heating at 
50, 60, 70, 80, 90 oC for five minutes, respectively. 7-12) sample injected after heating at 
100 oC for 30 seconds and 1, 2, 3, 4, 5 minutes. 
 
3.1.3 Circular dichroism spectroscopy studies 
 The secondary structures of T1D, T1Dfoldon and RD3Nfoldon samples were 
assessed using CD spectroscopy analysis. Single runs of these samples yielded CD 
spectra at 25 oC between 190 and 250 nm as shown in Figure 3.9. 
For the T1D and T1Dfoldon samples CD spectra showed a-helical spectrum 
with a maximum at short wavelength followed by two minima at longer wavelengths. 
These results are in accordance with the typical -helical protein spectra showing that 
T1D and T1Dfoldon samples were able to fold into a helical structure [113].   
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Figure 3.9. Circular dichroism spectra of the -helical T1D and foldon samples. T1D, 
T1Dfoldon and RD3foldon samples are colored as red, blue and black, respectively. 
 
 CD spectra for RD3Nfoldon showed a minimum at about 208 nm which is a 
characteristic of the  structure [114]. Foldon domain has a finger print at 228 nm and 
RD3Nfoldon sample revealed a pronounced maximum at this wavelength showing that 
this protein is correctly folded [88]. However, for T1Dfoldon sample this characteristic 
peak for the foldon domain was absent indicating that foldon domain could not trimerize 
T1D AFP. This was also consistent with the thermal hysteresis results where we have 
seen that T1Dfoldon was not even as active as the T1D itself showing the incorrect 
folding of the T1Dfoldon sample (Figure 19).  
 
3.1.4 Expression and purification of RD3CCys and nfe8EGFPCys 
 One other protein, RD3-C-Cys, was expressed after producing and transforming 
the gene into the host strain. 1 L culture of RD3CCys expression time course showed that 
the protein was accumulated in inclusion bodies and the level of protein expression was 
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slightly increased from 2 to 6 hours as can be seen from Figure 3.10. Molecular weight of 
this protein was calculated as 7536.8 g/mol from the DNA sequence and it is in good 
agreement with the SDS-page results. 
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Figure 3.10. Tris-tricine gel of the time course of RD3CCys expression. Lanes 1 and 16 
are the molecular weight markers. Lanes 1 and 2 are the low and high range molecular 
weight markers. Lane 2 is the is the insoluble fraction preinduction control. Lanes 3-5 are 
the insoluble fractions of 6 hour postinduction period from 2 to 6 hours, respectively. 
Similarly, lane 6 is the soluble fraction preinduction control and lanes 7-9 are the soluble 
fractions of 6 hour postinduction period. Lane 10 corresponds to the purified protein. 
  
nfe8EGFPCys was also found to be in the inclusion bodies as can be seen from 
Figure 3.11. Protein expression slightly increased from 2 to 4 hours and remained the 
same afterwards. 
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Figure 3.11. Tris-tricine gel of the time course of nfe8EGFPCys expression. Lanes 1 and 
6 are the low and high range molecular weight markers. Lane 2 is the insoluble fraction 
preinduction control. Lanes 3-5 are the insoluble fractions of 6 hour postinduction period 
from 2 to 6 hours, respectively. Similarly, lane 7 is the soluble fraction preinduction 
control and lanes 8-10 are the soluble fractions of 6 hour postinduction period.  
 
 It is important to note that both RD3CCys and nfe8EGFPCys have cysteine 
residues that are prone to disulfide bond formation leading to dimerization. In order to 
prevent this, tris[2-carboxyethyl] phosphine (TCEP) was added to the solutions in the 
purification steps [96]. TCEP is not stable in phosphate buffers. In fact, a small fraction 
of RD3CCys was dimerized even after addition of TCEP, explaining the necessity of 
performing disulfide bond reducing reaction immediately before use [115].  
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3.2 Characterization of the protein constructs 
 Type I and type III AFPs produced in this study were characterized using several 
methods such as size exclusion HPLC, thermal hysteresis measurements and circular 
dichroism spectroscopy. Following section describes the size exclusion HPLC studies of 
the reaction products. 
 
3.2.1 Size exclusion studies of the reaction products 
 
3.2.1.1 T1N/PAA reaction 
T1N was reacted with PAA through its carboxy terminus using EDC/sulfoNHS 
chemistry. After the reaction is completed, 500 µl aliquot of the reaction mixture was 
injected to the size exclusion column to see the size distribution of the conjugated 
proteins. In size exclusion, molecules are separated by the differences in their sizes. 
Bigger molecules elute from the column first, followed by small molecules. The reason 
for this is that bigger molecules can not enter into the pores of the column material 
having only the void volume excluded by the packing material to travel throughout the 
column. On the other hand, small ones can access the additional volume of the small 
pores and eluted later. This method has been used to isolate antifreeze molecules [6, 116, 
117]. Figure 3.12 shows the size exclusion profile of the reaction mixture. The first peak 
corresponds to the reacted product which has a much higher molecular weight than the 
reactants, which are 17 kDa PAA and 5.1 kDa T1N. The second peak is the unreacted 
protein peak (labeled as 4) as there is no significant signal showing the presence of PAA. 
It is seen that the reaction product initially elutes closely behind the void volume (6 ml), 
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while unreacted T1N eluted 14 minutes after the injection. Samples were fractionated as 
labeled in Figure 3.12 and analyzed to determine the thermal hysteresis activities and the 
ice crystal morphologies and discussed in the following sections. 
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Figure 3.12. Size exclusion HPLC results of the T1N/PAA reaction mixture. Black line: 
230 nm, red line: 280 nm. 
 
3.2.1.2 RD3CCys/PAA reaction 
RD3CCys was reacted with PAA through its N-terminus cysteine. After the 
reaction is completed, 500 µl aliquot of the reaction mixture was injected to the size 
exclusion column to see the size distribution of the conjugated proteins at both 230 and 
280 nm. Figure 3.13 shows the size exclusion profile of the reaction mixture. The first 
peak corresponds to the reacted product which has a much higher molecular weight than 
the reactants, which are 17 kDa PAA and 7.5 kDa RD3CCys. The second peak is the 
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unreacted protein peak as can also be understood from the increased absorbances at 280 
nm because RD3CCys has a stronger signal at this wavelength as compared to the PAA.  
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Figure 3.13. Size exclusion HPLC results of the RD3CCys/PAA reaction mixture. Solid 
line: 230 nm, dashed line: 280 nm. 
 
It is seen from Figure 3.13 that the reaction product started to be eluted shortly 
after the void volume, while unreacted RD3CCys eluted 14 minutes after the injection. 
Fractions corresponding to the peaks 1 and 2 were collected for thermal hysteresis 
activity determinations and discussed in the following sections.  
 
3.2.1.3 nfe8EGFPCys/PAA reaction 
nfe8EGFPCys was reacted with PAA through its C-terminus cysteine. After the 
reaction is completed, 100 µl aliquot of the reaction mixture was injected to the size 
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exclusion column to see the size distribution of the conjugated proteins at both 230 and 
280 nm. Figure 3.14 shows the size exclusion profile of the reaction mixture. The first 
peak corresponds to the reacted product which has a much higher molecular weight than 
the reactants, which are 17 kDa PAA and 36.3 kDa nfe8EGFPCys. The second peak is 
the unreacted protein peak as can also be understood from the increased absorbances at 
280 nm because nfe8EGFPCys has a stronger signal at this wavelength as compared to 
the PAA.  
It is seen from Figure 3.14 that the reaction product started to be eluted shortly 
after the void volume similar to what was observed with the RD3CCys reaction, while 
unreacted nfe8EGFPCys eluted 14 minutes after the injection. Fractions corresponding to 
the peaks 1 and 2 were collected for thermal hysteresis activity determinations and 
discussed in the following sections.  
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Figure 3.14. Size exclusion HPLC results of the nfe8EGFPCys/PAA reaction mixture. 
Solid line: 230 nm, dashed line: 280 nm. 
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3.2.2 Thermal hysteresis studies 
 The most common way to characterize the AFP activity is to test thermal 
hysteresis of the protein. Thermal hysteresis is given by the difference between melting 
and freezing temperatures of an AFP solution. The greater the thermal hysteresis value, 
more active the AFP is. Unlike colligative properties of the other solutes where their 
effect is directly proportional to their concentration, AFPs show a noncolligative effect 
lowering the freezing point. This property allows them to act as antifreeze at much lower 
concentrations than the other antifreezes such as methanol and polyethylene glycol [5, 
118].  
 Figure 3.15 shows the concentration dependency of the thermal hysteresis for 
T1D, T1N and T1N/PAA reaction product. All three protein constructs exhibited thermal 
hysteresis activities. Although T1D and T1N have comparable activities up to 0.2 mM, 
the activity for T1N was reduced at high concentrations. The reason for reduced thermal 
hysteresis activity of T1N may be due to the lack of aspartic acid residues that were 
removed to facilitate site directed conjugation reactions. This protein became highly 
insoluble after the removal of the acidic residues which seems to play a role affecting the 
thermal hysteresis activity. When compared to reported thermal hysteresis values of its 
shorter isoform HPLC-6, T1D is more active for the concentrations lower than 2 mM 
[58]. As can be seen from Figure 3.15, in low concentration region, T1N/PAA reaction 
product was approximately twice as active when compared to T1D or T1N. This is 
consistent with our hypothesis that the addition of multiple AFPs to a polymer chain 
would increase the concentration of the surface bound proteins especially at low 
concentrations thereby increasing the activity of the product also by decreasing the 
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probability of these molecules being desorbed from the ice surface. Hence, we would 
need to use lesser amount of protein to obtain the same activity in the case of the reaction 
product.   
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Figure 3.15. Concentration dependence of thermal hysteresis for T1D, T1N and the 
T1N/PAA reaction product measured at a rate of 0.01 oC/min. 
 
 In Figure 3.16, thermal hysteresis activities of T1D and T1Dfoldon were 
compared. It was observed that having a foldon domain lowered the thermal hysteresis 
activity of T1D. This is consistent with CD and gel electrophoresis data showing that the 
folding of the foldon is interrupted. The reason for this may be that the highly 
hydrophobic residues of the T1D protein causes them to interact with each other 
especially when they are in close proximity caused by the foldon domain attached to 
them which prevents poor association with the surrounding solvent required for folding. 
We also note that, this construct was designed to have a 9-residue linker which would 
allow enough space between them for proper folding by estimating the minimum linker 
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length limited by the diameter of the alpha helix (1.2 nm). This linker can be kept longer 
to facilitate proper folding of the T1Dfoldon construct. 
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Figure 3.16. Concentration dependence of thermal hysteresis for T1D and T1Dfoldon 
measured at a rate of 0.01 oC/min. Error bars represent the standard deviation values 
calculated from 3 different measurements. 
 
 This was not the case for the type III AFPs. RD3Nfoldon showed significantly 
increased activity as compared to its monomer, RD3N (Figure 3.17). This increase was 
more pronounced for the low concentration region where the foldon sample was 8 times 
as active as the monomer. The difference in their activities was lowered to approximately 
2.5 fold for concentrations greater than 1 mM. This is due to the decreased number of ice 
surface sites available for protein adsorption leading to the diminishing effect of having a 
trimer instead of a monomer.   
 RD3N thermal hysteresis data was consistent with literature [47]. In a study 
performed by Nishimiya et al., they have showed that multimers of type III AFP showed 
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improved thermal hysteresis activity. They have designed multimers of RD3N by tandem 
repetition of these molecules connected by the original 9-residue linker of the RD3 [69]. 
They have observed thermal hysteresis activity of approximately 0.74 oC for 0.5 mM 
protein concentration, whereas RD3Nfoldon of this study significantly improved this 
activity and yielded a value of approximately 1.38 oC at the same protein concentration. 
The major reason for this improved effect observed in the presence of RD3Nfoldon as 
compared to previously reported study [47] is due to the uniqueness of the design. RD3N 
AFPs were trimerized using a foldon domain allowing the individual domains were free 
to move independently via a flexible 9-residue linker [45] and they were able to engage 
with the surface more easily as compared to the ones designed in a previous study [47]. 
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Figure 3.17. Concentration dependence of thermal hysteresis for RD3N and RD3Nfoldon 
measured at a rate of 0.01 oC/min. Error bars represent the standard deviation values 
calculated from 2 and 3 different measurements for RD3N and RD3Nfoldon, 
respectively. 
 
 65
 Conjugation reactions of type III AFPs with PAA worked well in terms of 
improved thermal hysteresis activities as can be seen from Figure 3.18. nfe8EGFPCys 
reaction improved the thermal hysteresis activity of the protein from 0.4 to 0.65 oC at 0.4 
mM solution concentration. This improvement was more pronounced at lower 
concentrations where the thermal hysteresis activity of the protein was approximately 
doubled and tripled at 0.07 and 0.01 mM, respectively. For RD3CCys reaction, thermal 
hysteresis activity was increased for only up to 0.15 mM as compared to the protein 
alone. This might be due to the inability of the C-domain of RD3 to fold when it is 
connected to another domain. Because the C domain alone shows a typical thermal 
hysteresis activity for a single domain type III AFP [69].  
The activity of the size exclusion fractions from Figure 3.13 and 3.14 was 
investigated. For both reactions, it was seen that first and second peaks were active 
showing the presence of the AFPs in both fractions. The activity of the first and second 
fractions from Figure 3.13 were 0.08 and 0.04 oC, respectively. Similarly, the activities of 
the first two fractions from Figure 3.14 were 0.13 and 0.06 oC, respectively. This proves 
the presence of the reaction product in the first fraction for both reactions. 
 It is seen from Figure 3.18 that nfe8EGFPCys yielded slightly higher thermal 
hysteresis values than RD3CCys. Similar findings were reported for the fusion type III 
proteins. Introduction of the fusion proteins (maltose binding protein and Thioredoxin) 
improved the activity of the protein itself [119]. This was explained by the well known 
Kelvin effect [76]. According to this model, activity increase in the presence of the fusion 
proteins was attributed to the more ice surface covered by the fusion proteins and it is 
harder for the ice to grow over them. Hence, if these bigger molecules are covering more 
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of the surface, they would create larger ice curvatures leading to the lowering of the 
freezing point due to the increased energy barrier for the addition of the water molecules. 
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Figure 3.18. Concentration dependence of thermal hysteresis for the type III AFP 
constructs and their reaction products measured at a rate of 0.01 oC/min. Error bars 
represent the standard deviation values calculated from 3 different measurements. 
 
3.2.3 Ice crystal morphologies 
 Ice crystal morphologies were observed in the presence of the AFPs. It has been 
previously shown that AFPs of different types produce different ice crystal morphologies 
which is attributed to their structural differences [63]. Type I AFPs were found to be 
bound to the bipyramidal (201) plane of ice [76]. Molecular modeling studies revealed 
that the main source of this interaction was the steric compatibility between the ice plane 
and the AFP [82]. Type III AFPs were reported to bind to the prism (100) plane of the ice 
crystal [81]. Similarly, steric contributions and hydrophobic interactions were found to 
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play an important role in ice binding of these AFPs by molecular dynamics simulations, 
ice docking and energy minimization studies [42, 76, 80, 120].  
 In Figure 3.19, ice crystal morphologies in the presence of T1D AFPs for different 
concentrations were presented. C-axis is shown parallel to the paper plane. In all 
concentrations, similar ice crystals were obtained (10-15 μm) except at 0.53 mM, where 
slighlty bigger ice crystals were observed compared to the lower concentrations. It is 
shown that T1D initially produces truncated bipyramidal ice crystals and then complete 
bipyramid shape was recovered over time. Hexagonal bipyramidal ice crystal 
morphologies were reported in the presence of the shorter isoform of T1D [113]. At the 
burst point, it is observed that ice crystals failed at the tip growing along the c-axis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.19. Ice crystal morphologies in the presence of T1D. c-axis is parallel to the 
paper plane. Rows 1 to 3 represent 0.53, 0.26 and 0.02 mM T1D concentrations, 
respectively.  
 
 T1N AFP generally failed to form complete bipyramidal structures especially at 
low concentrations (Figure 3.20). Truncated ice crystals are clearly visible for 0.24 mM 
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sample, where the c-axis is perpendicular to the paper plane. Surprisingly, for T1N AFP, 
burst point morphology was different than its isoform, T1D. Ice crystals were failed at the 
tip and at the center of the crystal but ice crystal growth was always along the a-axis, 
which is parallel to the paper plane at 0.24 mM.  
 
 
 
Figure 3.20. Ice crystal morphologies in the presence of T1N. c-axis is parallel to the 
paper plane except for the second row for which c-axis is perpendicular to the paper 
plane. Protein concentrations are as follows: Rows 1 to 3: 0.60, 0.24, 0.02 mM, 
respectively.  
 
 Ice crystal morphologies of the T1N/PAA reaction product revealed similar 
behavior as T1N AFP alone except that much finer ice crystals were obtained even at 
very low concentrations as can be seen from Figure 3.21. Again, failure occurred at the 
tip and at the center of the ice crystal carrying similarities from T1N protein. 
 
 69
 
 
Figure 3.21. Ice crystal morphologies in the presence of the T1N/PAA reaction mixture. 
c-axis is parallel to the paper plane. Protein concentrations in rows 1 and 2 are 30 and 3 
µM, respectively.  
 
 The first and second peaks of T1N with PAA purified by size exclusion HPLC 
(Figure 3.12) were fractionated and ice crystal morphologies were observed. Thermal 
hysteresis activities of the samples from first row to the forth row are 0.25, 0.28, 0.2, 0.11 
oC, respectively (Figure 3.22). No ice crystal morphology change was detected for the 
remainder of the peaks indicating that the first two peaks constitute the majority of the 
reacted and unreacted protein (data not shown).  
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Figure 3.22. Ice crystal morphologies in the presence of the HPLC purified T1N/PAA 
reaction product. c-axis is parallel to the paper plane except for the third row, which is 
perpendicular to the paper plane. From left to right: Initial single ice crystal, ice crystal 
right before growth and right after growth, respectively. First row is the left arm of the 
first peak in Figure 3.12, while the remaining rows represent the top-right of the first 
peak, bottom-right of the first peak and the second peak in Figure 3.12, respectively. 
 
 Ice crystal morphologies of the other AFP constructs were also investigated. 
These results are presented in Figure 3.23. Although T1Dfoldon sample does not improve 
thermal hysteresis activity, it does alter the ice crystal morphology and form perfectly 
shaped bipyramidal ice crystals (Figure 3.23-A). For this sample, failure occurred along 
the a-axis which is perpendicular to the paper plane as expected.  
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Figure 3.23. Ice crystal morphologies in the presence of the AFP constructs. (A) 
T1Dfoldon solution (0.91 mM). (B) RD3Nfoldon solution (0.6 mM). (C) RDCCys 
solution (2.3 mM). (D) RD3CCys reaction mixture. (E) nfe8EGFPCys solution (0.69 
mM). In all cases, c-axis is parallel to the paper plane.  
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 For the RD3Nfoldon sample, c-axis to a-axis ratio was decreased significantly 
forming finer ice crystals (Figure 3.23-B). Very rapid ice growth along the c-axis was 
observed at the freezing point. RD3CCys was also formed diamond shaped small ice 
crystals (10 μm) and burst point morphologies were similar to that of RD3Nfoldon 
(Figure 3.23-C). Similar observations were made in a previous study for a single domain 
type III AFP [118]. RD3CCys reaction mixture produced bigger ice crystals (30μm) and 
the ice crystal growth was observed along the c-axis (Figure 3.23-D). 
 Ice crystal morphology in the presence of nfe8EGFPCys was investigated using a 
fluorescence microscope in order to visualize where the fluorescence protein binds to the 
ice crystal (Figure 26-E). The first column in Figure 3.23-E is the 14 nl nfe8EGFPCys 
solution suspended in immersion oil. Second column in the same row is the single ice 
crystal and the last column shows the burst point morphology. It is seen that the protein 
molecules are surrounding the diamond shaped ice crystal and it fails along the c-axis.     
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CHAPTER IV 
 
MODELING OF ANTIFREEZE PROTEIN ADSORPTION 
 
Langmuir adsorption isotherm models are used to relate thermal hysteresis and 
surface coverage values of single-domain and two-domain type III AFP using previously 
published thermal hysteresis versus concentration data [61]. Surface coverage and 
binding energy are determined by fitting two independent thermal hysteresis data sets 
with the classical Langmuir isotherm and a modified isotherm for the one- and two-
domain proteins, respectively. Such a comparison is possible because all of the domains 
have identical structures and should have equivalent binding energies. We first describe 
the model systems with the governing equations, then derive the isotherms, and finally 
use these with experimental data to relate thermal hysteresis with surface coverage. This 
study is also extended to three domain type III AFPs and governing equations are given 
in the following sections. 
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4.1 Model systems for a single, two- and three-domain antifreeze protein 
 We are modeling the reversible adsorption of two different protein configurations 
onto an ice crystal: a single domain (Figure 4.1-A) and two of the single domains 
connected by a flexible linker (Figure 4.1-B). For the two domain protein, the adsorbed 
protein can exist in two states: with one of the domains adsorbed to the ice surface 
allowing the second domain to freely diffuse only limited by the extent of the linker 
(state I) and with both domains adsorbed to the ice surface (state II). Equations used to 
describe these two processes are given in the following section. It is important to note 
that NMR analyses of the two-domain type III AFP clearly indicates that the linker is 
flexible allowing them to move independently of each other [46, 121]. 
kd 
ka2 
kd 
ka1 
kd 
ka 
 
  A      B 
Figure 4.1. Adsorption of proteins to the ice lattice. (A) Single domain type III AFP 
adsorbs reversibly onto the ice lattice with an adsorption rate constant of ka. (B) The two-
domain type III AFP adsorbs onto the ice lattice in a two-step process. State I represents 
the adsorption of the first domain while state II is the two-domain adsorbed state. The 
corresponding adsorption rate constants are ka1 and ka2. In all cases, desorption is 
governed by the desorption rate constant kd. Binding faces are shaded. 
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After modeling two-domain AFP adsorption, we are now modeling the reversible 
adsorption of three-domain AFP (Figure 4.2-A). RD3Nfoldon is an example of such a 
molecule where three of the single domains all having linkers are held together by a 
foldon domain. For the three domain protein, the adsorbed protein can exist in three 
states: (a) with one of the domains adsorbed to the ice surface (Figure 4.2-B) allowing the 
other two domains to freely diffuse only limited by the extent of the linkers (state I), (b) 
with two domains adsorbed to the ice surface (Figure 4.2-C) (state II), and (c) all three 
domains adsorbed to the ice surface (Figure 4.2-D) (state III). Equations used to describe 
these three processes are given in the following section. 
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Figure 4.2. Adsorption of three- domain proteins to the ice lattice. (A) Three-domain 
type III AFP in the solution. (B), (C) and (D) represents three-domain type III AFP 
adsorption reversibly onto the ice lattice with adsorption rate constants of ka1, ka2 and ka3, 
respectively. State I represents the adsorption of the first domain while state II and state 
III are the two- and three-domain adsorbed state. In all cases, desorption is governed by 
the desorption rate constant kd. 
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4.2 Langmuir isotherm 
Langmuir equilibrium isotherm equation is widely used to describe equilibrium 
adsorption phenomena. It was developed for gas adsorption but has been extensively 
applied to adsorption from solution. It has been used previously to describe the 
adsorption of antifreeze glycoproteins (AFGP) and AFP to ice [62, 78]. The assumption 
is made that the protein binds as a monolayer to equivalent surface binding sites that are 
independent, i.e. binding at one site does not affect the binding at other sites. This 
assumption is consistent with what is known about AFPs.   
The kinetic equation for a single domain protein molecule (Figure 4.1-A) can be 
written as: 
 da kCkdt
d  )1(       (4.1) 
where,   is the fractional surface coverage, t  is time,  is the concentration of the 
protein in the solution,  and  are the adsorption and desorption rate constants, 
respectively. When the adsorption reaches equilibrium (i.e. 
C
ak dk
  is constant), the Langmuir 
isotherm equation results [122]: 
KC
KC
 1          (4.2) 
where K  is the equilibrium binding constant, 
d
a
k
kK            (4.3) 
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4.3 Modified Langmuir isotherm for two-domain antifreeze protein 
 
The Langmuir model is modified to account for the two step process of binding a 
two-domain protein using the same assumptions in the classical Langmuir model with the 
additional assumptions that the adsorption and desorption rate constants are equivalent 
for each domain and that the desorption rate constants are not affected by whether the 
other domain is bound or unbound. When all terms that contribute to formation or 
elimination of state I are considered, the kinetic equation for state I is 
21211
1 )1()1(  dTadTa kkkCkdt
d     (4.4) 
where 1  and 2  are the fractional surface coverage values for state I and state II, 
respectively, and 21  T .  Increasing 1  comes about by either adsorption of one 
domain from solution with a rate constant of  (first term in equation (4.4)) or by 
desorption of one of the domains of a protein with both domains bound to the surface 
(state II) with a rate constant of  (last term in equation (4.4)). Similarly, decreasing 
1ak
dk 1
dk
 
includes desorption of the singly bound domain into solution with a rate constant of  
(second term in equation (4.4)) and adsorption of the second domain to the ice surface 
with a rate constant of ka2 resulting in a state II protein (third term in equation (4.4)). It 
should be noted that the adsorption of protein to the surface (the first and third terms) is 
modulated by the total number of available sites for binding, 1T . 
A kinetic equation can similarly be expressed for state II:  
212
2 2)1(2  dTa kkdt
d       (4.5) 
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where the factors of two arise because the surface coverage of a protein in state II is 
twice as large as a protein in state I. 
Desorption rate constants for the domains in each state were taken as , since it 
is assumed that the desorption rate does not depend on the number of domains bound to 
the surface. At equilibrium, equations (4.4) and (4.5) can be equated to zero, solved for 
dk
T : 
CKKKCKKKCKKT
11
2
11
2
11
2
11
2
1
21
2
221221
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

   (4.6) 
where  and  are the equilibrium binding constants for state I and state II, 
respectively. 
1K 2K
 
4.4 Modified Langmuir isotherm for three-domain antifreeze protein 
The Langmuir model is also modified to account for the three-step process of 
binding a three-domain protein using the same assumptions in the modified Langmuir 
model.  
When all terms that contribute to formation or elimination of state I are 
considered, the kinetic equation for state I is 
21211
1 )1()1(  dTadTa kkkCkdt
d     (4.7) 
where 1  and 2  are the fractional surface coverage values for state I and state II, 
respectively. Increasing 1
1a
 comes about by either adsorption of one domain from solution 
with a rate constant of k  (first term in equation (4.7)) or by desorption of one of the 
domains of a protein with two domains bound to the surface (state II) with a rate constant 
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of  (last term in equation (4.7)). Similarly, decreasing dk 1
dk
 includes desorption of the 
singly bound domain into solution with a rate constant of  (second term in equation 
(4.7)) and adsorption of the second domain to the ice surface with a rate constant of ka2 
resulting in a state II protein (third term in equation (4.7)). It should be noted that the 
adsorption of protein to the surface (the first and third terms) is modulated by the total 
number of available sites for binding, 1T . 
A kinetic equation can similarly be expressed for state II:  
323212
2 2)22)1(2  1(  dadTa kkkkd  Tdt    (4.8) 
where the factors of two arise because the surface coverage of a protein in state II is 
twice as large as a protein in state I. 
Similarly, kinetic equation for state III is expressed as:  
323
3 3)1(3  dTa kkd dt        (4.9) 
where,  is the adsorption rate constant of the third domain and 3 is the fractional 
surface coverage for state III and 
3ak
321   T . Here, the factor of 3 is embedded into 
the equation 4.9 because the protein in state III has three times larger surface area than 
the protein in state I. Also, in this case there are three possible detachments of any of the 
three domains bound to the surface leading to the formation of state II.  
At equilibrium, equations (4.7), (4.8) and (4.9) are equated to zero, and after 
appropriate substitutions, an algebraic cubic equation for T  is obtained, where ,  
and  are the equilibrium binding constants for states I, II and III, respectively. 
1K 2K
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321321
12
3
3 
CKKKCKKK
CK
K TTT
  (4.10) 
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 Solution for T is given by: 
327422742
1 3
32
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32 apqqpqq
T     (4.11) 
where,  
27
92 3 abacq   and 
3
2abp  . Here, a, b and c are the coefficients of the second, 
third and the last term in equation 4.10, respectively. 
 
4.5 Relating surface coverageto thermal hysteresis activity 
Experimental data is measured as thermal hysteresis versus concentration, yet 
the equilibrium isotherm equations provide surface coverage ( ) versus concentration. It 
is necessary to relate thermal hysteresis to  . This has been done previously by defining 
a fractional thermal hysteresis activity, which is the ratio between the thermal hysteresis 
temperature at a given concentration and the maximum attainable thermal hysteresis 
temperature of that solution [62, 78]. It was suggested that this ratio should be a function 
of surface coverage, which barring any experimental data the values were simply 
approximated to be proportional. 
In our analysis we do not assume any the relationship between thermal hysteresis 
and surface coverage. We instead explicitly determine it based on the adsorption 
isotherms described above (equations (4.2) and (4.6)). We directly relate surface 
coverage ( to thermal hysteresis (TH) through the concentration dependencies. The 
adsorption isotherm relationships provide the surface coverage as a function of 
concentration, (C), and experimental data gives us thermal hysteresis as a function of 
concentration, TH(C). Combining these functions, we can eliminate concentration and 
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determine the function TH().  One issue with this approach is that the Langmuir 
equation is dependent on an unknown equilibrium binding constant (K), leaving us with 
two unknowns, K and . However, since we have two independent data sets (the one- and 
two-domain proteins), so we can solve for both equilibrium constant and surface 
coverage.  
For this procedure to work, the relationship between surface coverage and 
thermal hysteresis should not be affected by the coupling of domains with the nine-
residue linker. As discussed below this may not hold for very low surface coverage, but 
should hold at higher surface coverage where there is significant binding at neighboring 
binding sites.  
Equation (4.2) was used to calculate the surface coverage with respect to the 
concentration values that correspond to the experimental thermal hysteresis values 
reported [61]. Similarly, T  values were calculated for the two-domain adsorption from 
equation (4.6) from equivalent data. These data sets are in themselves ambiguous, 
because the equilibrium binding constants are not known. Thermal hysteresis versus total 
surface coverage data were then fit to each other so that they would coincide using the 
equilibrium constants K1 and K2 as fitting parameters. In this procedure, we define an 
objective function F, which is in essence a function of K1 and K2: 
0),,(),(),( 2121121  iii THKKTHKKKF     (4.12) 
where, subscript i denotes the ith experimental point and  and  represent the fractional 
surface coverage values for state 1 and state II, respectively. Equation (4.12) was solved 
by minimizing the sum of the squares of the function Fi.  
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In order to fit the two isotherm equations, a relationship between the equilibrium 
constants (K, K1, and K2) needs to be established.  The ice binding regions of the protein 
are identical and in the two domain protein the domains are linked well outside the 
binding region, it is assumed that the binding energies for each domain are equivalent, 
and therefore, all else being equivalent, the binding constants for each domain are the 
same.  However, for the two domain protein, K1 and K2 are affected by the coupling of 
the domains.  
For K1, the protein has two independent binding domains, either of which could 
bind to the ice surface contributing to the binding described by the k1a rate constant in 
equation 4. This would result in an effective doubling of the equilibrium binding constant 
suggesting that K1 = 2K, equivalent to double the concentration of the single domain 
protein. The two domains, however, are not completely independent; they are confined to 
be within the nine-residue linker length apart. This means that they may not behave as 
though there is twice single domain concentration. The adsorption of a protein consists of 
two steps: the Brownian motion (diffusion) of the protein to the surface, followed by one 
or more collisions with the surface with some probability of sticking upon each collision. 
For a very low sticking probability, the rate of binding is limited by the number of 
collisions, which will be determined by the short-range Brownian movement of the 
domains once it is near to the surface. In this case having two domains with independent 
local mobility will give you twice the collision frequency, and double the equilibrium 
binding constant. However, for a high sticking probability, the rate will be limited by the 
bulk Brownian diffusion that brings the protein close enough to the surface to initiate a 
collision. In this case, having two domains is not advantageous, because the two domains 
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will diffuse to the surface as one species. In this case the equilibrium binding constant K1 
will be equivalent to K (or even slightly lower due to the smaller diffusion constant for 
the two domain protein). If the sticking and diffusion occur with similar rates, K1 would 
lie somewhere between K and 2K.   
Although the equilibrium constants K1 and K2 were calculated as independent 
fitting parameters (equation 4.12), they can be related to each other by defining an 
“effective concentration” that can be used to interpret the data resulting from the curve 
fitting procedure. Since in state I the free domain is confined by the linker to a specific 
volume, an “effective concentration” of this domain can be calculated. This effective 
concentration (Ceff) can be used to relate the equilibrium constants: 
K2  Ceff K1        (4.13) 
To calculate the effective concentration an estimation of the volume available 
for the free domain to diffuse is needed. In Figure 4.3, four possible orientations of the 
second domain are shown with the first domain attached to the ice surface. The volume 
that maps all possible orientations of the second domain can be approximated as a 
hemisphere, whose volume was taken as a basis to calculate the effective concentration. 
Radius of the hemisphere was approximated as ~ 4 nm by adding the size of one domain 
and the full length of the nine residue linker. Then calculating the concentration of one 
domain in the volume of the hemisphere results in 2.3 mM as the effective concentration. 
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Figure 4.3. Illustration of the origin of the effective concentration. Four possible 
orientations of the two-domain type III AFP are shown adsorbed onto the ice lattice in 
state I for visualization of effective concentration. Shaded surfaces correspond to the ice 
binding faces. 
Equilibrium constants K1 and K2 were calculated for the two extreme situations 
described above: collision limited (K1 = 2K) and diffusion limited (K1 = K) adsorption. In 
both cases the fits described the data well for fractional surface coverages greater than 
0.2.  The effective concentration (K2/K1) for diffusion and collision limited cases were 
calculated to be 2.6 and 0.6 mM, respectively. When these values are compared to the 
estimated value for the effective concentration, 2.3 mM, it is seen that the diffusion 
limited case fits the data more closely. For this reason, our calculations are based on the 
diffusion limited case and hence the equilibrium constants K1 and K2, were calculated as 
1.9 mM-1 and 5, respectively. 
The results of the fitting the data (Figure 4.4) illustrates that there is a good 
agreement between experimental thermal hysteresis values and surface coverage 
calculated from the isotherm equations. The thermal hysteresis values for surface 
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coverage greater than 0.2 are the same for the single domain and the two-domain type III 
AFPs. However, at surface coverage below 0.2, it is observed that the single domain type 
III AFP gives higher thermal hysteresis for equivalent surface coverage. 
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Figure 4.4. Thermal hysteresis as a function of surface coverage. Experimental thermal 
hysteresis data for the single domain (●) and the two-domain type III AFPs (■). Solid and 
dashed lines represent the classical and modified Langmuir isotherms, respectively. 
With a binding constant for the protein, the energetics of binding a single 
domain can be determined in terms of the Gibbs free energy: 
KRTG o ln          (4.14) 
where, K  is the adsorption equilibrium constant. Using this relationship, Gibbs free 
energy of binding for type III AFP at 0˚C is -4.1 kcal/mol (-7.6 kT). It should be noted 
that Gibbs free energy was calculated using the binding constant of the one domain 
protein, which is equivalent to the individual domains in the two-domain protein, i.e K = 
K1 = K2/Ceff. 
Classical and modified Langmuir isotherms were applied to one- and two-
domain type III AFPs using the equilibrium constants calculated for state I and state II, 
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which are 1.9 mM-1 and 5, respectively (Figure 4.5). Equilibrium constant for one-
domain protein was taken as 1.9 mM-1. It is clearly seen from Figure 4.5 that two-domain 
protein surface coverage values are greater than the ones for the one-domain protein at 
low concentrations and the difference between them becomes smaller for higher 
concentrations.   
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Figure 4.5. Classical and modified Langmuir isotherms applied to one- and two-domain 
type III AFP adsorption, respectively.  
For the three- domain antifreeze protein adsorption, equilibrium constant K3 was 
calculated using a similar data mapping technique applied for one- and three-domain 
proteins. RD3N and RD3Nfoldon thermal hysteresis data were used in the one- and three-
domain calculations, respectively. As a result of the fitting procedure, K1, K2 and K3 were 
calculated as 0.49 mM-1, 7.8 and 31.1, respectively. It is seen from Figure 4.6 that three-
domain protein surface coverage values are greater than the ones for the one- domain 
protein especially at low concentrations and the difference between them becomes 
smaller for higher concentrations. The same data were plotted against domain 
concentration in order to see the effect of the multiple domains more clearly. For this, 
? two-domain
one-domain
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surface coverage values were plotted against the solution concentration multiplied by 3 
for the three-domain AFP. The improved surface coverage values of the three-domain 
AFP are observed from Figure 4.7 when compared to one- domain AFP. The effect of 
multimerization is more pronounced when the data are plotted against the solution 
concentration. The improved effect of three-domain AFP is slightly diminished but is still 
significantly greater at low concentrations when it is plotted against domain 
concentration which means that the surface coverage in the presence of three-domain 
AFP is significantly enhanced at per domain level.  
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Figure 4.6. Classical and modified Langmuir isotherms applied to one- and three-domain 
type III AFP adsorption, respectively. 
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Figure 4.7. Classical and modified Langmuir isotherms applied to one- and three-domain 
(per domain) type III AFP adsorption, respectively. Surface coverage values were 
calculated as per domain basis where, concentration for three-domain AFP was 
multiplied by three. 
 
The results of the fitting data (Figure 4.8) illustrates that there is a good 
agreement between experimental thermal hysteresis values and surface coverage 
calculated from the isotherm equations. In the case of three-domain AFPs we have 
obtained more data for higher surface coverage and thermal hysteresis values than we 
have obtained for one- and two-domain AFPs. The fitting curve bends up for high surface 
coverage values and approaches to a limiting thermal hysteresis value of about 2 oC 
determined by the number of surface sites left that are available for adsorption. 
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Figure 4.8. Thermal hysteresis as a function of surface coverage. Experimental thermal 
hysteresis data for the single domain (●) the three-domain type III AFPs (■). 
 
4.6 Kinetic analyses 
Time related information about one and two-domain protein adsorption was 
obtained by rewriting equations (4.1), (4.4) and (4.5) by dividing both sides of the 
equations by kd: 
  )1(
)(
KC
tkd
d
d
      (4.15) 
21211
1 )1()1(
)(
  TT
d
KCK
tkd
d    (4.16) 
212
2 2)1(2
)(
  T
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K
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where,  is dimensionless time. The term, kd, is the desorption rate constant, which is 
combined with time, t, in order to calculate the surface coverage values with respect to 
dimensionless time. Since the value of the equilibrium constant is known, determining 
dtk
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the adsorption or desorption rate constant would permit the calculation of the real time 
from the dimensionless time term. This data is not readily available, and so only the 
dimensionless time data is presented. Equation (4.15) was solved numerically to give 
(tkd) and equations (4.16) and (4.17) were solved simultaneously to determine 1 tkd  
and 2 tkd  , where the summation of the last two yielded T tkd   (Figure 4.9). The 
equilibrium surface coverage are obtained at high tkd and have been used to corroborate 
the analytical expression derived for surface coverage. Additionally, a comparison of 
two-domain AFP in states I and II gives us a picture of the density of the protein at the 
ice surface. As the surface has higher coverage, there is a higher proportion of proteins 
with only one domain bound (state I). 
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Figure 4.9. Surface coverage values with respect to dimensionless time at different 
solution concentrations. (A) C= 0.1 mM, (B) C= 1 mM, (C) C= 5 mM, (D) C= 10 mM. 
Surface coverage values are given for state I (x), state II (+), state I and state II total (■), 
and single domain (●). 
The interaction of antifreeze proteins with ice crystal surfaces has been 
compared to the interaction between a receptor (AFP) and ligand (ice) [9]. However, 
determining the corresponding binding affinity (equilibrium binding constant) and 
fraction of ligands bound (surface coverage) is experimentally difficult because of the 
dynamic nature of the ice-water interface. Within this study, we determined the binding 
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affinity and relationship between surface coverage and thermal hysteresis for a type III 
antifreeze protein.   
This was accomplished because of the availability of data on a unique two-
domain construct of this protein [61].  The two domains of the protein are identical in 
structure and are connected by a nine-residue flexible linker, resulting in enhanced 
thermal hysteresis activity at low solution concentrations [61]. The two domains of an 
identically linked naturally found protein (RD3) have been shown to move independent 
of each other, enabling the domains to bind to the surface independently, indicating that 
the observed increase in activity comes from an increased avidity rather than increased 
affinity of protein [46]. Because the binding of the two domain protein can include a 
second binding step, the concentration dependence of surface coverage is governed by a 
different relationship than the single domain protein. However, the relationship between 
surface coverage and thermal hysteresis should be the same because the AFP domains 
binding to the ice surface are identical in structure. Since the binding affinities of the 
domains of the one- and two-domain proteins are the same, the independent thermal 
hysteresis data for the one- and two-domain proteins can be used to determine the two 
unknowns of the binding affinity and surface coverage. 
This is different than other instances where the activity of AFP has been altered. 
For several different types of AFP, it has been demonstrated that increasing the ice 
binding surface area of the protein increases the antifreeze activity. For instance, the 
helical proteins such as those from winter flounder and Tenebrio molitor, have exhibited 
increased thermal hysteresis by extending the length of the protein [68, 71]. The activity 
increase is attributed to an increased affinity for the surface by increasing the binding 
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face or size of the protein [123, 124]. Point mutations have also been shown to affect the 
thermal hysteresis by reducing the geometric fit of the protein to the ice surface [56, 125]. 
This also is attributable to a change in the affinity for the ice surface. In these cases, each 
time a new set of thermal hysteresis data is added, an additional unknown binding affinity 
is also introduced. This always leaves one more unknown than sets of data. The two 
domain constructs are the only AFPs known to alter activity through avidity. 
The first step in obtaining the binding constants and surface coverage was to 
modify the Langmuir adsorption isotherm to include the two-step binding process of the 
two-domain protein. It should be noted that this isotherm may be of more general use for 
the adsorption of other molecules that have two independent adsorbing regions, such as 
bolaform surfactants [126] or tri-block copolymers [127]. In fact, the same principle 
could be generalized to calculate an isotherm for multi-domain adsorbates such as the 
three- and four-domain AFPs developed by Nishimiya et al. [69], comb-like polymer 
surfactants [128], or other molecular architectures with multiple independent binding 
regions.   
The fit of the experimental data sets results in the master thermal hysteresis 
versus surface coverage plot (Figure 4.5). The thermal hysteresis values obtained for a 
given surface coverage are the same for the single domain and the two-domain type III 
AFPs for surface coverage values greater than 0.2, showing a very good fit for the two 
sets of data. However, as noted above, there is a deviation between one- and two-domain 
type III AFP at low surface coverage. The single domain protein yields higher thermal 
hysteresis for the same surface coverage. One might initially attribute this to larger errors 
in the measurement of low thermal hysteresis values. But looking deeper, this can be 
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explained by the average spacing between adsorbates on the ice crystal lattice. Thermal 
hysteresis is attributed to the Kelvin effect, where the ice crystal growth is inhibited by 
the increased curvature of ice growing between adsorbed proteins [129]. The smaller the 
distance between proteins, the larger the thermal hysteresis is. Figure 4.10 shows 
examples of 10 and 50% surface coverage for one- and two-domain proteins. At 10% 
coverage, the surface is sparsely populated with protein. It makes sense that molecular 
spacing between adsorbed protein molecules would be higher for two-domain AFP 
molecules at the same surface coverage, because the two domains of the two-domain 
protein will adsorb on neighboring sites, leaving more open space for a given surface 
coverage. However, having a second domain will no longer have a significant effect at 
higher surface coverage where there is a similarly high probability of single domain 
proteins occupying neighboring sites. This transition occurs around 20-25% surface 
coverage. 
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Figure 4.10. One- and two-domain protein adsorption on an ice lattice. Circles and 
connected circles represent the surface sites that are occupied by one- and two-domain 
protein molecules, respectively. The first column is an example of 10% surface coverage, 
the second column has 50% surface coverage. 
 
In previous work, the Langmuir equation was used to model thermal hysteresis 
data [78] and estimate the binding energy of type I winter flounder AFP [62]. Since the 
relationship between thermal hysteresis and the surface coverage of protein was not 
available, they made the approximation that the thermal hysteresis is proportional to 
fractional surface coverage with a proportionality constant of the estimated maximum 
thermal hysteresis. This presumed linear relationship fit the thermal hysteresis data to a 
first approximation. Our data (Figure 4.5) illustrates that their approximation was 
adequate (particularly for higher surface coverage), but breaks down at lower surface 
coverage where we observe significant deviation from linearity. 
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The binding constant for the type III AFP domain was determined to be 1.9 mM-
1. This corresponds to an equilibrium dissociation constant (Kd) of 0.53 mM, which is 
very weak in terms of typical receptor-ligand interactions. The corresponding -4.1 
kcal/mol (7.6 kT) binding energy is indicative of a significant, but relatively weak 
interaction compared to the expected energy of interaction for an “irreversibly” bound 
protein. This is consistent with theoretical predictions for the type I AFPs that exhibit 
similar thermal hysteresis activities [62]. 
The reversible process with weak binding is compatible with the reversible step 
of AFP interaction with ice as described by Kristiansen and Zachariassen [6]. However, 
instead of a simple partitioning of the protein into an interfacial region as proposed in 
their model, our data analysis is consistent with direct AFP interact with the ice crystal 
during this reversible step. It has been shown that two linked AFP domains are not 
sufficient to increase the thermal hysteresis, but that the domains must be able to have an 
orientation where they can both bind to the surface [61]. If AFPs were not interacting 
with the ice crystal surface during the reversible step, having an additional domains in the 
protein structure would not have any effect on the activity. However, it has been shown 
that multimers of type III AFPs significantly enhance thermal hysteresis activity [61, 69]. 
Therefore, AFPs must interact with the ice surface in order to justify the differences in 
the activities.  
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CHAPTER V 
 
SUMMARY 
 
We have succesfully expressed and characterized several type I and type III AFP 
constructs in order to increase the thermal hysteresis activity. These proteins were 
modified to create AFP multimers using genetic engineering and bioconjugation 
techniques. Our results revealed that type III AFP trimer, RD3Nfoldon sample was the 
most active yielding 1.65 oC thermal hysteresis activity at 1.8 mM. Many of the reaction 
products of these protein constructs gave rise to a much better thermal hysteresis 
activities than the AFPs alone. This improvement in the thermal hysteresis activities were 
more pronounced especially at low concentrations. 
In addition, we have successfully developed new relationships to describe two- 
and three-domain protein adsorption based on classical Langmuir model. These modified 
isotherms were used successfully to characterize the adsorption of two- and three-domain 
antifreeze proteins onto an ice surface, illustrating that the Langmuir adsorption model is 
sufficient to describe AFP adsorption to an ice crystal. Using classical and modified 
Langmuir model, the relationship between surface coverage and thermal hysteresis 
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activity was obtained for a type III antifreeze protein, as well as equilibrium binding 
constants. It should be noted that modified Langmuir isotherms derived in this study can 
be of general use and can be further modified and extended to other molecular constructs 
with multiple independent binding regions.  
It is crucial to further investigate the role of the AFP multimers for their increased 
thermal hysteresis activities in order to make them better candidates for cryopreservation 
and heat transfer fluid additives. It has been shown in this study that the novel AFP 
constructs have increased activities which should lead to other studies to find possibly 
more active AFPs. Perhaps originally hyperactive insect AFPs can be oligomerized to 
broaden the thermal hysteresis window. More importantly, designing superior AFP 
constructs which would have considerable thermal hysteresis activities at significantly 
low concentrations would make it much more economical to use them as an additive in 
these systems. Bioreactor systems can be designed and optimized to produce AFPs in 
large quantities along with the optimized down stream conjugation reactions and 
purification methodologies. Developing molecular biology techniques and bioconjugation 
technology will shed light to designing novel synthetic materials that are suitable to use 
in such applications.  
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APPENDIX 
 
A.1 Protein expression/purification protocol 
Protein expression: 
- Make 5 ml starter culture with (100 μg amplicilin per ml) and grow cells at 37 oC 
overnight. 
- Put entire culture into 1L LB (Lysogeny broth) and grow cells at 37 oC until the optical 
density reaches 0.6 at 600 nm UV wavelength. 
- Induce protein expression with 120 mg IPTG. 
- Centrifuge the cell culture after six hours and freeze the pellet. 
 
Protein extraction: 
- Resuspend the cell pellet in 10 ml BPER. 
- Centrifuge at 27000g for 15 minutes. 
- Pour off supernatant and resuspend the pellet in BPER. 
- Add 10 mg/ml lysozyme and incubate at room temperature for five minutes. 
- Add 20 ml 1:10 diluted BPER and centrifuge at 27000g for 15 minutes. 
- Pour off supernatant and resuspend the pellet in 30 ml 1:20 diluted BPER. 
- Centrifuge at 27000g for 15 minutes. 
- Repeat resuspension and centrifugation steps two more times. 
- Resuspend the final pellet in 6M Guanadine HCl. 
- Dilute the solution 20 fold using refolding buffer (50 mM K2PO4, 100 mM NaCl). 
- Chill solution at 4oC for 3 days. 
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Purification and desalting: 
- Dialyze the solution against acetic acid (pH 3.7) for 2-3 days with subsequent 
repetitions. 
-  After final dialysis, centrifuge at 27000g for 15 minutes. 
-  Retain supernatant for lyophilizing. 
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A.2 PCR protocol 
Resuspend oligonucleotides in TE buffer to a concentration of 100 μM. 
Prepare 10 μM stock solutions for future use (keep the original solution in -80 oC 
freezer). 
 50 μl reaction prepared in PCR tubes: 
- 1 μl template primer 
- 5 μl forward primer 
- 5 μl reverse primer 
- 25 μl PCR master mix 
- 14 μl nuclease free water 
Place PCR tubes in a thermocycler. 
Adjust the desired program. 
 Sample program: 
- 2 minutes at 95 oC for melting the DNA 
- 30 cycles of: 
- 1 minute at 72 oC for annealing the primers to the DNA. 
- 30 seconds at approximately 5 oC below the melting point of the 
primers for primer extension. 
- 1 minute at 72 oC for the primer extention. 
- Refrigeration at 4 oC for several hours until the sample is removed form the  
thermocycler. 
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A.3 Agarose gel electrophoresis protocol 
Preparing 1.5% agarose gel: 
- Add 1.125 g agarose (molecular biology grade) in a beaker containing 75 ml 1X TAE 
buffer (cover with aluminum foil). 
- Stir and heat until clean liquid is formed. 
- Allow it to cool down. 
- Add 7.5 μl ethidium bromide and mix by swirling. 
- Pour the solution in a cassette and place the appropriate combs for sample injection. 
- Allow it to cool down to room temperature. 
- Remove the combs and place the gel in a gel box. 
- Fill the gel box with 1X TAE solution. 
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A.4 Polyacrylamide gel electrophoresis running protocol 
Tris-tricine gel electrophoresis: 
1. Prepare 10X Tris-tricine SDS running buffer stock solution (pH 8.3). 
- 10X solution (1 L): 
  - 1M Tris base 
  - 1M Tricine 
  - 1% SDS 
Tris-glycine gel electrophoresis: 
2. Prepare 10X Tris-glycine SDS running buffer stock solution (pH 8.3). 
- 10X solution (1 L): 
  - 0.25 M Tris base 
  - 1.92 M Glycine 
  - 1% SDS 
Protocol for running the gel: 
3. Dilute 10X either Tris-tricine or Tris-glycine running Buffer to 1X in double distilled 
water 
4. Prepare samples in 6X sample buffer 
- 6X sample buffer: 
   - 375 mM Tris-HCl (pH 6.8) 
   - 9 w% SDS 
   - 50% Glycerol 
   - 0.02% Bromophenol blue 
   - 375 mM DTT 
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5. Prepare molecular weight markers in 2X sample buffer 
6. Electrophorese the gel at 100 volts until the dye front is near the bottom of the gel 
(approximately 2 hours). 
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A.5 Type I AFP purification protocol 
1.  Dissolve cell pellets from 1 L culture in 60 ml, 70% ethanol. 
2.  Heat this suspension in water bath at 75 oC for 30 minutes with occasional shaking. 
3.  Centrifuge at 14000g for 20 minutes. 
4.  Discard the pellet and keep the ethanol soluble protein. 
5.  Add four volume of chilled acetone and store the solution at 20 oC overnight. 
6.  Centrifuge at 14000g for 45 minutes. 
7.  Discard the solution and allow the acetone precipitate to dry at room temperature. 
8.  Resuspend the pellet in 40 ml of 100 mM ammonium bicarbonate. 
9.  Add 40 ml of saturated ammonium sulfate. 
10. Centrifuge at 6300g for 30 minutes. 
11. Discard the solution and resuspend the pellet in 40 ml of 100 mM ammonium 
bicarbonate. 
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A.6 Protein concentration determination 
Protein concentrations (except T1D and T1N. Amino acid analysis was used to 
determine the concentrations of these two proteins) were determined by calculating the 
molar extinction coefficients by following the procedure given by Gill and Hippel [109] 
as explained in the Experimental section. The calibration curves are presented in the 
following figures. 
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Figure A.1. Calibration curve for RDCCys concentration determination. C is the 
concentration of the unknown sample relative to the original sample prepared. Lines 
represent the linear fit to the UV280 absorbance versus concentration data.  
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Figure A.2. Calibration curve for nfe8EGFPCys concentration determination. C is the 
concentration of the unknown sample relative to the original sample prepared. Lines 
represent the linear fit to the UV280 absorbance versus concentration data.  
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Figure A.3. Calibration curve for RD3Nfoldon concentration determination. C is the 
concentration of the unknown sample relative to the original sample prepared. Lines 
represent the linear fit to the UV280 absorbance versus concentration data.  
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Figure A.4. Calibration curve for T1Dfoldon concentration determination. C is the 
concentration of the unknown sample relative to the original sample prepared. Lines 
represent the linear fit to the UV280 absorbance versus concentration data. Equations and 
correlation coefficients (R2) of the linear fit are presented near the corresponding data. 
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A.7 Thermal hysteresis measurement protocol 
1. Prepare the protein sample at different concentrations. 
2. Inject immersion oil into one of the sample wells using a plastic tubing-Pasteur 
pipette-bulb assembly. 
3. Place the nanoliter osmometer assembly onto the microscope stage. 
4. Fill the needle attached to the automatic injector with immersion oil. 
5. Fill the tip of the needle with the sample. 
6. Inject approximately 14 nl sample (for 300 μm droplet) into the oil. 
7. Assemble cooling water tubing. 
8. Turn on the video controller, light source, computer and VCR. 
9. Cover and seal the entire microscope with plastic bag. 
10. Connect adsorbent column to the pump and other end onto the sample stage  
11. Operate the pump for 15 minutes prior to start cooling the stage. 
12. Start flowing chilled water through plastic tubing. 
13. Turn on the osmometer temperature controller and bring it to the “freeze” mode. 
14. After freezing, switch to the normal mode. 
15. Disconnect chilled water line and connect to the tap water line. 
16. Wait for 5 minutes for thermal equilibrium and start thawing the sample slowly until 
obtaining one single ice crystal. 
17. Start taking pictures either using the computer or VCR. 
18. Wait for 5 minutes for thermal equilibrium and decrease the temperature by 0.01 oC 
every minute until ice crystal starts growing. 
19. Repeat the experiment three times for each sample. 
